(19)
(11)EP 3 444 241 B1

(12)EUROPEAN PATENT SPECIFICATION

(45)Mention of the grant of the patent:
03.08.2022 Bulletin 2022/31

(21)Application number: 18173452.6

(22)Date of filing:  21.05.2018
(51)International Patent Classification (IPC): 
C07D 307/91(2006.01)
H01L 51/50(2006.01)
C07C 211/61(2006.01)
(52)Cooperative Patent Classification (CPC):
C07C 2603/18; C07C 2603/40; H01L 51/0058; H01L 51/5056; C07C 211/61; C07D 307/91; H01L 51/006; H01L 51/0073; C09K 11/06

(54)

AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

AMINBASIERTE VERBINDUNG UND DIESE ENTHALTENDE ORGANISCHES LICHTEMITTIERENDES ELEMENT

COMPOSÉ AMINÉ ET DISPOSITIF ÉLECTROLUMINESCENT ORGANIQUE CONTENANT CE COMPOSÉ


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 18.08.2017 KR 20170105081

(43)Date of publication of application:
20.02.2019 Bulletin 2019/08

(73)Proprietor: Samsung Display Co., Ltd.
Gyeonggi-do (KR)

(72)Inventors:
  • KIM, Jongwoo
    Gyeonggi-do (KR)
  • BAEK, Jangyeol
    Gyeonggi-do (KR)
  • JEONG, Eunjae
    Gyeonggi-do (KR)
  • HAN, Sanghyun
    Gyeonggi-do (KR)
  • KIM, Youngkook
    Gyeonggi-do (KR)
  • HWANG, Seokhwan
    Gyeonggi-do (KR)

(74)Representative: Mounteney, Simon James 
Marks & Clerk LLP 15 Fetter Lane
London EC4A 1BW
London EC4A 1BW (GB)


(56)References cited: : 
WO-A1-2014/065391
WO-A1-2014/106522
JP-A- 2015 119 166
US-A1- 2014 131 681
WO-A1-2014/088285
WO-A1-2016/064111
US-A1- 2008 160 347
  
      
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


    Description

    BACKGROUND


    1. Field



    [0001] Aspects of one or more embodiments of the present invention relate to an organic light-emitting device including an amine-based compound. Amine-based compounds are also disclosed herein.

    2. Description of the Related Art



    [0002] Organic light-emitting devices are self-emission devices that have wide viewing angles, high contrast ratios, short response times, and excellent characteristics in terms of brightness, driving voltage, and response speed, compared to devices in the art.

    [0003] An organic light-emitting device may include a first electrode on a substrate, and a hole transport region, an emission layer, an electron transport region, and a second electrode sequentially positioned on the first electrode. Holes provided from the first electrode may move toward the emission layer through the hole transport region, and electrons provided from the second electrode may move toward the emission layer through the electron transport region. The carriers (e.g., holes and electrons) may recombine in the emission layer to produce excitons. Then, the excitons may transition from an excited state to a ground state, thereby releasing energy in the form of light. US 2014/131681 A1 relates to an amine compound having a benzofluorene structure and further having a dibenzofuran structure and/or a dibenzothiophene structure.

    WO 2014/065391 A1 relates to a benzofluorene compound.

    JP 2015 119166 A relates to a composition for forming a light-emitting layer.

    WO 2014/106522 A1 relates to a compound for use in an electronic device.

    US 2008/160347 A1 relates to a benzofluorene compound.

    WO 2016/064111 A1 relates to an organic electronic device and display apparatus.

    WO 2014/088285 A1 relates to a compound for an organic electronic element.


    SUMMARY



    [0004] One or more aspects of embodiments of the present invention provide an organic light-emitting device including an amine-based compound. Amine-based compounds are also disclosed herein.

    [0005] Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments.

    [0006] One or more aspects of embodiments of the present invention provide an organic light-emitting device including: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, wherein the organic layer includes an emission layer, a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, and the hole transport region comprises at least one amine-based compound represented by one of Formulae 1-1 to 1-6:















    wherein:
    1. i) when the amine-based compound is represented by Formula 1-1, R2 to R10 are each hydrogen;
    2. ii) when the amine-based compound is represented by Formula 1-2, R8 and R9 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a methyl group, an ethyl group, a propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a ter-butyl group, a pentyl group, an iso-amyl group, a hexyl group, a phenyl group, and a biphenyl group, and R1, R3 to R7, and R10 are each hydrogen;
    3. iii) when the amine-based compound is represented by Formula 1-3, R1, R2, and R4 to R10 are each hydrogen;
    4. iv) when the amine-based compound is represented by Formula 1-4, R1 to R3 and R5 to R10 are each hydrogen;
    5. v) when the amine-based compound is represented by Formula 1-5, R1 to R7 and R9 to R10 are each hydrogen; or
    6. vi) when the amine-based compound is represented by Formula 1-6, R2 is selected from hydrogen, deuterium, -F, -CI, -Br, -I, a methyl group, an ethyl group, a propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a ter-butyl group, a pentyl group, an iso-amyl group, a hexyl group, and a biphenyl group, and R1, R3 to R8, and R10 may each be hydrogen.

    L1, and L2 are each independently a substituted or unsubstituted C5-C60 carbocyclic group or a substituted or unsubstituted C2-C60 heterocyclic group,

    a1 and a2 are each independently an integer from 0 to 5, wherein, when a1 is two or more, two or more L1(s) are identical to or different from each other, and when a2 is two or more, two or more L2(s) are identical to or different from each other,

    when a1 is zero, *-(L1)a1-*' is a single bond, and when a2 is zero, *-(L2)a2-*' is a single bond,

    Ar1 and Ar2 are each independently selected from:

    a benzene group; and

    a benzene group substituted with at least one selected from deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, a C2-C20 heteroaryl group, and -Si(Q31)(Q32)(Q33).

    R11 and R12 are each independently selected from a group represented by any of Formulae 6-1 to 6-10, 6-12 to 6-18 and 6-27 to 6-34:











    [0007] In Formulae 6-1 to 6-10, 6-12 to 6-18 and 6-27 to 6-34,

    Ph indicates a phenyl group, and

    * indicates a binding site to a neighboring atom.

    b1 and b2 are each independently an integer from 1 to 10, wherein, when b1 is two or more, two or more R11(s) are identical to or different from each other, and when b2 is two or more, two or more R12(s) are identical to or different from each other,

    at least one substituent of the substituted C5-C60 carbocyclic group and the substituted C2-C60 heterocyclic group is selected from:

    deuterium (-D), -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group;

    a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group, each substituted with at least one selected from deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q11)(Q12)(Q13), - B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11), and -P(=O)(Q11)(Q12);

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q21)(Q22)(Q23), - B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21), and -P(=O)(Q21)(Q22); and

    -Si(Q31)(Q32)(Q33), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31), and - P(=O)(Q31)(Q32),

    Q1 to Q3, Q11 to Q13, Q21 to Q23, and Q31 to Q33 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, and

    * indicates a binding site to a neighboring atom.



    [0008] Another aspect of the invention provides an organic light-emitting device including: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, wherein the organic layer includes an emission layer, a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, and the hole transport region comprises at least one amine-based compound selected from any of Compounds 1 to 7, 9 to 19 and 21 to 144.

    [0009] At least some of the above and other features of the invention are set out in the claims.

    BRIEF DESCRIPTION OF THE DRAWINGS



    [0010] These and/or other aspects will become apparent and more readily appreciated from the following description of the example embodiments, taken in conjunction with the accompanying drawings, in which:

    FIG. 1 is a schematic view of an organic light-emitting device according to embodiments of the present disclosure;

    FIG. 2 is a schematic view of an organic light-emitting device according to embodiments of the present disclosure;

    FIG. 3 is a schematic view of an organic light-emitting device according to embodiments of the present disclosure; and

    FIG. 4 is a schematic view of an organic light-emitting device according to embodiments of the present disclosure.


    DETAILED DESCRIPTION



    [0011] The present disclosure will now be described more fully with reference to example embodiments. Advantages, features, and how to achieve such advantages and features of the present invention will become apparent by reference to the embodiments described in detail herein, together with the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as being limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the concept of the disclosure to those skilled in the art.

    [0012] Hereinafter, embodiments are described in more detail by referring to the attached drawings, in which like reference numerals denote like elements and duplicative descriptions thereof may not be provided.

    [0013] As used herein, the singular forms "a", "an", and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.

    [0014] It will be further understood that the terms "comprises" and/or "comprising" may be used herein to specify the presence of stated features or components, but do not preclude the presence or addition of one or more other features or components.

    [0015] It will be understood that when a layer, region, or component is referred to as being "on" or "onto" another layer, region, or component, it may be directly or indirectly formed on the other layer, region, or component. That is, for example, intervening layers, regions, or components may be present. In contrast, when an element is referred to as being "directly on" another element, no intervening elements are present.

    [0016] The sizes and thicknesses of components in the drawings may be exaggerated for convenience of explanation. In other words, since sizes and thicknesses of components in the drawings are arbitrarily illustrated for convenience of explanation, the following embodiments of the present disclosure are not limited thereto.

    [0017] Disclosed herein is an amine-based compound represented by Formula 1 below:







    [0018] Ar1, Ar2, L1, and L2 in Formulae 1 and 2 are each independently a substituted or unsubstituted C5-C60 carbocyclic group or a substituted or unsubstituted C2-C60 heterocyclic group.

    [0019] For example, Ar1, Ar2, L1, and L2 may each independently be a substituted or unsubstituted C5-C30 carbocyclic group or a substituted or unsubstituted C2-C30 heterocyclic group. For example, Ar1, Ar2, L1, and L2 may each independently be a substituted or unsubstituted C5-C20 carbocyclic group or a substituted or unsubstituted C2-C20 heterocyclic group.

    [0020] For example, Ar1, Ar2, L1, and L2 may each independently be selected from:

    a benzene group, a pentalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, an acenaphthalene group, a fluorene group, a spiro-fluorene group, a benzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphenylene group, a hexacene group, a pyrrole group, an imidazole group, a pyrazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an iso-indole group, an indole group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a carbazole group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzoxazole group, a benzimidazole group, a furan group, a benzofuran group, a thiophene group, a benzothiophene group, a thiazole group, an isothiazole group, a benzothiazole group, an isoxazole group, an oxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a benzoxazole group, a dibenzofuran group, a dibenzothiophene group, a benzocarbazole group, and a dibenzocarbazole group; and

    a benzene group, a pentalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, an acenaphthalene group, a fluorene group, a spiro-fluorene group, a benzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphenylene group, a hexacene group, a pyrrole group, an imidazole group, a pyrazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an iso-indole group, an indole group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a carbazole group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzoxazole group, a benzimidazole group, a furan group, a benzofuran group, a thiophene group, a benzothiophene group, a thiazole group, an isothiazole group, a benzothiazole group, an isoxazole group, an oxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a benzoxazole group, a dibenzofuran group, a dibenzothiophene group, a benzocarbazole group, and a dibenzocarbazole group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, a C2-C20 heteroaryl group, and -Si(Q31)(Q32)(Q33),

    wherein Q31 to Q33 are each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 (e.g. C1-C20) alkyl group, a C2-C60 (e.g. C2-C20) alkenyl group, a C2-C60 (e.g. C2-C20) alkynyl group, a C1-C60 (e.g. C1-C20) alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 (e.g. C6-C30) aryl group, a C1-C60 (e.g. C1-C20) heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group.



    [0021] For example, L1 and L2 may each independently be selected from a group represented by any of Formulae 3-1 to 3-46:





















    [0022] In Formulae 3-1 to 3-46,

    Y1 is O, S, C(Z3)(Z4), N(Z5), or Si(Z6)(Z7),

    Z1 to Z7 are each independently selected from hydrogen, deuterium, -F, -CI, - Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, and - Si(Q31)(Q32)(Q33),

    d2 is an integer from 0 to 2, wherein, when d2 is two, two Z1(s) are identical to or different from each other,

    d3 is an integer from 0 to 3, wherein, when d3 is two or more, two or more Z1(s) are identical to or different from each other and two or more Z2(s) are identical to or different from each other,

    d4 is an integer from 0 to 4, wherein, when d4 is two or more, two or more Z1(s) are identical to or different from each other,

    d5 is an integer from 0 to 5, wherein, when d5 is two or more, two or more Z1(s) are identical to or different from each other and two or more Z2(s) are identical to or different from each other,

    d6 is an integer from 0 to 6, wherein, when d6 is two or more, two or more Z1(s) are identical to or different from each other and two or more Z2(s) are identical to or different from each other,

    d8 is an integer from 0 to 8, wherein, when d8 is two or more, two or more Z1(s) are identical to or different from each other, and

    * and *' each indicate a binding site to a neighboring atom.



    [0023] a1 and a2 in Formula 2 are each independently an integer selected from 0 to 5. a1 indicates the number of Li(s), wherein, when a1 is two or more, two or more L1(s) are identical to or different from each other. a2 indicates the number of L2(s), wherein, when a2 is two or more, two or more L2(s) are identical to or different from each other.

    [0024] When a1 is zero, *-(L1)a1-*' is a single bond, and when a2 is zero, *-(L2)a2-*' is a single bond.

    [0025] For example, a1 and a2 may each independently be 0 or 1.

    [0026] For example, Ar1 and Ar2 may each independently be selected from:

    a benzene group; and

    a benzene group substituted with at least one selected from deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, a C2-C20 heteroaryl group, and -Si(Q31)(Q32)(Q33), but embodiments of the present disclosure are not limited thereto.



    [0027] For example, Ar1 and Ar2 may each independently be selected from a group represented by any of Formulae 5-1 to 5-80:









































    [0028] In Formulae 5-1 to 5-80,

    Y31 is O, S, C(Z33)(Z34), N(Z35), or Si(Z36)(Z37),

    Z31 to Z37 are each independently selected from hydrogen, deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, and -Si(Q31)(Q32)(Q33),

    e2 is an integer from 0 to 2, wherein, when e2 is two, two Z32(s) are identical to or different from each other,

    e3 is an integer from 0 to 3, wherein, when e3 is two or more, two or more Z31(s) may be identical to or different from each other and two or more Z32(s) may be identical to or different from each other,

    e4 is an integer from 0 to 4, wherein, when e4 is two or more, two or more Z31(s) are identical to or different from each other and two or more Z32(s) are identical to or different from each other,

    e5 is an integer from 0 to 5, wherein, when e5 is two or more, two or more Z31(s) are identical to or different from each other and two or more Z32(s) are identical to or different from each other,

    e6 is an integer from 0 to 6, wherein, when e6 is two or more, two or more Z31(s) are identical to or different from each other and two or more Z32(s) are identical to or different from each other,

    e7 is an integer from 0 to 7, wherein, when e7 is two or more, two or more Z31(s) are identical to or different from each other,

    e9 is an integer from 0 to 9, wherein, when e9 is two or more, two or more Z31(s) are identical to or different from each other, and

    * indicates a binding site to a neighboring atom.



    [0029] R1 to R10 in Formula 1 are each independently selected from a group represented by Formula 2, hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkyl group, a substituted or unsubstituted C2-C60 (e.g. C2-C20) alkenyl group, a substituted or unsubstituted C2-C60 (e.g. C2-C20) alkynyl group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C2-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryloxy group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) arylthio group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, -Si(Q1)(Q2)(Q3), -B(Q1)(Q2), -C(=O)(Q1), -P(=O)(Q1)(Q2), - P(=S)(Q1)(Q2), -S(=O)(Q1)(Q2), and -S(=O)2(Q1)(Q2),

    provided that one selected from R1 to R10 is a group represented by Formula 2, and

    R11 and R12 are each independently selected from hydrogen, deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkyl group, a substituted or unsubstituted C2-C60 (e.g. C2-C20) alkenyl group, a substituted or unsubstituted C2-C60 (e.g. C2-C20) alkynyl group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C2-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryloxy group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) arylthio group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, -Si(Q1)(Q2)(Q3), - B(Q1)(Q2), -C(=O)(Q1), -P(=O)(Q1)(Q2), -P(=S)(Q1)(Q2), -S(=O)(Q1)(Q2), and - S(=O)2(Q1)(Q2),

    wherein Q1 to Q3 may each independently be the same as described herein in connection with Q31 to Q33.



    [0030] For example, R1 to R10 may each independently be selected from a group represented by Formula 2, hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryl group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and -Si(Q1)(Q2)(Q3), and
    R11 and R12 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryl group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and - Si(Q1)(Q2)(Q3).

    [0031] For example, R1 to R10 may each independently be selected from a group represented by Formula 2, hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) alkyl group, a group represented by any of Formulae 5-1 to 5-80, and -Si(Q1)(Q2)(Q3), and
    R11 and R12 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 alkyl group, a group represented by any of Formulae 5-1 to 5-80, and -Si(Q1)(Q2)(Q3).

    [0032] For example, R11 and R12 may each independently be selected from a group represented by any of Formulae 6-1 to 6-34, but embodiments of the present disclosure are not limited thereto:















    [0033] In Formulae 6-1 to 6-34,

    Ph indicates a phenyl group, and

    * indicates a binding site to a neighboring atom.

    b1 and b2 in Formula 2 are each independently an integer selected from 1 to 10. b1 indicates the number of R11(s), wherein, when b1 is two or more, two or more R11(s) are identical to or different from each other. b2 indicates the number of R12(s), wherein, when b2 is two or more, two or more R12(s) are identical to or different from each other. In one or more embodiments, b1 and b2 may each be 1.



    [0034] For example, at least one substituent of the substituted C5-C60 (e.g. C5-C30) carbocyclic group, the substituted C2-C60 (e.g. C2-C30) heterocyclic group, the substituted C1-C60 (e.g. C1-C20) alkyl group, the substituted C2-C60 (e.g. C2-C20) alkenyl group, the substituted C2-C60 (e.g. C2-C20) alkynyl group, the substituted C1-C60 (e.g. C1-C20) alkoxy group, the substituted C3-C10 cycloalkyl group, the substituted C1-C10 heterocycloalkyl group, the substituted C3-C10 cycloalkenyl group, the substituted C1-C10 heterocycloalkenyl group, the substituted C6-C60 (e.g. C6-C30) aryl group, the substituted C6-C60 (e.g. C6-C30) aryloxy group, the substituted C6-C60 (e.g. C6-C30) arylthio group, the substituted C1-C60 (e.g. C1-C20) heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is selected from:

    deuterium (-D), -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 (e.g. C1-C20) alkyl group, a C2-C60 (e.g. C2-C20) alkenyl group, a C2-C60 (e.g. C2-C20) alkynyl group, and a C1-C60 (e.g. C1-C20) alkoxy group;

    a C1-C60 (e.g. C1-C20) alkyl group, a C2-C60 (e.g. C2-C20) alkenyl group, a C2-C60 (e.g. C2-C20) alkynyl group, and a C1-C60 (e.g. C1-C20) alkoxy group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 (e.g. C6-C30) aryl group, a C6-C60 (e.g. C6-C30) aryloxy group, a C6-C60 (e.g. C6-C30) arylthio group, a C1-C60 (e.g. C1-C20) heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q11)(Q12)(Q13), - B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11), and -P(=O)(O11)(Q12);

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 (e.g. C6-C30) aryl group, a C6-C60 (e.g. C6-C30) aryloxy group, a C6-C60 (e.g. C6-C30) arylthio group, a C1-C60 (e.g. C1-C20) heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 (e.g. C6-C30) aryl group, a C6-C60 (e.g. C6-C30) aryloxy group, a C6-C60 (e.g. C6-C30) arylthio group, a C1-C60 (e.g. C1-C20) heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 (e.g. C1-C20) alkyl group, a C2-C60 (e.g. C2-C20) alkenyl group, a C2-C60 (e.g. C2-C20) alkynyl group, a C1-C60 (e.g. C1-C20) alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 (e.g. C6-C30) aryl group, a C6-C60 (e.g. C6-C30) aryloxy group, a C6-C60 (e.g. C6-C30) arylthio group, a C1-C60 (e.g. C1-C20) heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q21)(Q22)(Q23), -B(Q21)(Q22), - C(=O)(Q21), -S(=O)2(Q21), and -P(=O)(Q21)(Q22); and

    -Si(Q31)(Q32)(Q33), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31), and - P(=O)(Q31)(Q32),

    wherein Q1 to Q3, Q11 to Q13, Q21 to Q23, and Q31 to Q33 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 (e.g. C1-C20) alkyl group, a C2-C60 (e.g. C2-C20) alkenyl group, a C2-C60 (e.g. C2-C20) alkynyl group, a C1-C60 (e.g. C1-C20) alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 (e.g. C6-C30) aryl group, a C1-C60 (e.g. C1-C20) heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, and

    * indicates a binding site to a neighboring atom.



    [0035] For example, the amine-based compound represented by Formula 1 may be selected from any of Compounds 1 to 144:





















































































    [0036] When the amine-based compound represented by Formula 1 satisfies a structure in which benzene is further condensed at a specific position of fluorene and a substituent having a cyclic structure is included at a specific position of fluorene (e.g., a fluorene group is substituted at the C9 position with a group having a cyclic structure and a phenyl ring of the fluorene group is further condensed with a benzene group), hole hopping may be facilitated by orbital delocalization. The amine-based compound may thus have high charge mobility, and therefore, an organic light-emitting device including the amine-based compound may be driven with low power.

    [0037] Also, when the amine-based compound includes one amino group within a molecule (e.g., is a monoamine compound), the amine-based compound may have a relatively low highest occupied molecular orbital (HOMO) energy level, as compared to a compound including two or more amino groups (e.g., a diamine, triamine, etc.). As such, the amine-based compound (e.g., monoamine compound) may have an energy level optimized for hole transport. Therefore, an electronic device, (for example, an organic light-emitting device) including the amine-based compound may have a low driving voltage, high efficiency, and a long lifespan.

    [0038] A synthetic method for preparing the amine-based compound represented by Formula 1 should be apparent to those of ordinary skill in the art by referring to the following examples.

    [0039] At least one of the amine-based compound represented by Formula 1 may be used between a pair of electrodes (e.g., in a layer positioned between a cathode and an anode) of an organic light-emitting device. For example, the amine-based compound may be included in at least one selected from a hole transport region, an electron transport region, and an emission layer. In one or more embodiments, the amine-based compound of Formula 1 may be used as a material for a capping layer located outside a pair of electrodes (e.g., in a layer that is not positioned between a cathode and an anode) of an organic light-emitting device.

    [0040] Accordingly, embodiments of the present invention provide an organic light-emitting device including: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, wherein the organic layer includes an emission layer, a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, and the hole transport region includes at least one amine-based compound represented by one of Formulae 1-1 to 1-6.















    wherein,
    1. i) when the amine-based compound is represented by Formula 1-1, R2 to R10 are each hydrogen;
    2. ii) when the amine-based compound is represented by Formula 1-2, R8 and R9 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a methyl group, an ethyl group, a propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a ter-butyl group, a pentyl group, an iso-amyl group, a hexyl group, a phenyl group, and a biphenyl group, and R1, R3 to R7, and R10 may each be hydrogen;
    3. iii) when the amine-based compound is represented by Formula 1-3, R1, R2, and R4 to R10 are each hydrogen;
    4. iv) when the amine-based compound is represented by Formula 1-4, R1 to R3 and R5 to R10 are each hydrogen;
    5. v) when the amine-based compound is represented by Formula 1-5, R1 to R7 and R9 to R10 are each hydrogen; or
    6. vi) when the amine-based compound is represented by Formula 1-6, R2 are selected from hydrogen, deuterium, -F, -CI, -Br, -I, a methyl group, an ethyl group, a propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a ter-butyl group, a pentyl group, an iso-amyl group, a hexyl group, and a biphenyl group, and R1, R3 to R8, and R10 may each be hydrogen,

      Ar1 and Ar2 are each independently selected from:

      a benzene group; and

      a benzene group substituted with at least one selected from deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, a C2-C20 heteroaryl group, and -Si(Q31)(Q32)(Q33),

      R11 and R12 are each independently selected from a group represented by any of Formulae 6-1 to 6-10, 6-12 to 6-18, and 6-27 to 6-34, and

      L1, L2, a1, a2, b1 and b2 in Formulae 1-1 to 1-6 are each the same as described in connection with Formula 1.



    [0041] Another aspect of the invention provides an organic light-emitting device including: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, wherein the organic layer includes an emission layer, a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, and the hole transport region comprises at least one amine-based compound selected from any of Compounds 1 to 7, 9 to 19 and 21 to 144.The expression "(a hole transport region) includes at least one amine-based compound", as used herein, may refer to a case in which (a hole transport region) includes identical amine-based compounds represented by one of Formulae 1-1 to 1-6, and may also refer to a case in which (a hole transport region) includes two or more different amine-based compounds represented by one of Formulae 1-1 to 1-6.

    [0042] In one or more embodiments, for example, the hole transport region may include only Compound 1 as the amine-based compound. In one or more embodiments, the hole transport region may simultaneously include Compound 1 and Compound 2 (e.g., a mixture of Compound 1 and Compound 2) as the amine-based compound. In this regard, Compound 1 and Compound 2 may exist in an identical (e.g., the same) layer, or may exist in different layers.

    [0043] In one or more embodiments, the first electrode may be an anode and the second electrode may be a cathode. The hole transport region may include a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and the electron transport region may include a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof.

    [0044] The hole transport regionincludes the amine-based compound (e.g., the amine-based compound represented by one of Formulae 1-1 to 1-6).

    [0045] In one or more embodiments, the hole transport region may include a hole transport layer, which includes the amine-based compound (e.g., the amine-based compound represented by one of Formulae 1-1 to 1-6).

    [0046] In one or more embodiments, the emission layer may include the amine-based compound represented by Formula 1.

    [0047] In one or more embodiments, the hole transport region may include a p-dopant, and the p-dopant may have a lowest unoccupied molecular orbital (LUMO) energy level of about -3.5 eV or less.

    [0048] In one or more embodiments, the emission layer may include at least one selected from a styryl-based compound, an anthracene-based compound, a pyrene-based compound, and a spiro-bifluorene-based compound.

    [0049] In one or more embodiments, the emission layer may be a first color light emission layer,

    the organic light-emitting device may further include: i) at least one second color light emission layer or ii) at least one second color light emission layer and at least one third color light emission layer, between the first electrode and the second electrode,

    a maximum emission wavelength of the first color light, a maximum emission wavelength of the second color light, and a maximum emission wavelength of the third color light may be identical to or different from each other, and,

    the first color light and the second color light may be emitted in the form of mixed light, or the first color light, the second color light, and the third color light may be emitted in the form of mixed light.



    [0050] The term "organic layer", as used herein, may refer to a single layer and/or a plurality of layers positioned between the first electrode and the second electrode of an organic light-emitting device. The materials included in the "organic layer" are not limited to being organic materials.

    [0051] FIG. 1 is a schematic view of an organic light-emitting device 10 according to an embodiment of the present disclosure. The organic light-emitting device 10 includes a first electrode 110, an organic layer 150, and a second electrode 190.

    [0052] Hereinafter, the structure of the organic light-emitting device 10 according to an embodiment of the present disclosure and a method of manufacturing the organic light-emitting device 10 will be described in connection with FIG. 1.

    [0053] In FIG. 1, a substrate may be additionally positioned under the first electrode 110 or above the second electrode 190. The substrate may be a glass substrate or a plastic substrate, each having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and water resistance.

    [0054] The first electrode 110 may be formed by depositing or sputtering a material for forming the first electrode 110 on the substrate. When the first electrode 110 is an anode, the material for forming a first electrode may be selected from materials with a high work function to facilitate hole injection.

    [0055] The first electrode 110 may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. When the first electrode 110 is a transmissive electrode, a material for forming a first electrode may be selected from indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO2), zinc oxide (ZnO), and any combination thereof, but embodiments of the present disclosure are not limited thereto. When the first electrode 110 is a semi-transmissive electrode or a reflective electrode, the material for forming the first electrode 110 may include magnesium (Mg), silver (Ag), aluminium (Al), aluminium-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), or any combination thereof. However, the material for forming the first electrode 110 is not limited thereto.

    [0056] The first electrode 110 may have a single-layered structure, or a multi-layered structure including two or more layers. For example, the first electrode 110 may have a three-layered structure of ITO/Ag/ITO, but the structure of the first electrode 110 is not limited thereto.

    [0057] The organic layer 150 is positioned on the first electrode 110. The organic layer 150 includes an emission layer.

    [0058] The organic layer 150 further includes a hole transport region between the first electrode 110 and the emission layer, and an electron transport region between the emission layer and the second electrode 190.

    [0059] The hole transport region may have: i) a single-layered structure including a single layer including a single material, ii) a single-layered structure including a single layer including a plurality of different materials, or iii) a multi-layered structure having a plurality of layers including a plurality of different materials.

    [0060] The hole transport region may include at least one layer selected from a hole injection layer (HIL), a hole transport layer (HTL), an emission auxiliary layer, and an electron blocking layer (EBL).

    [0061] For example, the hole transport region may have a single-layered structure including a single layer including a plurality of different materials, or a multi-layered structure having a hole injection layer/hole transport layer structure, a hole injection layer/hole transport layer/emission auxiliary layer structure, a hole injection layer/emission auxiliary layer structure, a hole transport layer/emission auxiliary layer structure, or a hole injection layer/hole transport layer/electron blocking layer structure, wherein the constituting layers of each structure are sequentially stacked on the first electrode 110 in their stated orders. However, the structure of the hole transport region is not limited thereto.

    [0062] The hole transport region includes the amine-based compound represented by one of Formulae 1-1 to 1-6.

    [0063] The hole transport region may include, in addition to the amine-based compound represented by one of Formula 1-1 to 1-6, at least one selected from m-MTDATA, TDATA, 2-TNATA, NPB (NPD), β-NPB, TPD, Spiro-TPD, Spiro-NPB, methylated-NPB, TAPC, HMTPD, 4,4',4"-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzenesulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphor sulfonic acid (PANI/CSA), polyaniline/poly(4-styrenesulfonate) (PANI/PSS), a compound represented by Formula 201, and a compound represented by Formula 202:















    [0064] In Formulae 201 and 202,

    L201 to L204 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 (e.g. C6-C32) arylene group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group,

    L205 may be selected from *-O-*', *-S-*', *-N(Q201)-*', a substituted or unsubstituted C1-C20 alkylene group, a substituted or unsubstituted C2-C20 alkenylene group, a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 (e.g. C6-C32) arylene group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group,

    xa1 to xa4 may each independently be an integer selected from 0 to 3,

    xa5 may be an integer selected from 1 to 10, and

    R201 to R204 and Q201 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C32) aryl group, a substituted or unsubstituted C6-C60 (e.g. C6-C32) aryloxy group, a substituted or unsubstituted C6-C60 (e.g. C6-C32) arylthio group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group.



    [0065] In one or more embodiments, in Formula 202, R201 and R202 may optionally be linked via a single bond, a dimethyl-methylene group, or a diphenyl-methylene group, and R203 and R204 may optionally be linked via a single bond, a dimethyl-methylene group, or a diphenyl-methylene group.

    [0066] In one or more embodiments, in Formulae 201 and 202,

    L201 to L205 may each independently be selected from:

    a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group; and

    a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C1-C10 alkyl group, a phenyl group substituted with -F, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, -Si(Q31)(Q32)(Q33), and -N(Q31)(Q32),

    wherein Q31 to Q33 may each independently be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.



    [0067] In one or more embodiments, xa1 to xa4 may each independently be 0, 1, or 2.

    [0068] In one or more embodiments, xa5 may be 1, 2, 3, or 4.

    [0069] In one or more embodiments, R201 to R204 and Q201 may each independently be selected from:

    a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group; and

    a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C1-C10 alkyl group, a phenyl group substituted with -F, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, -Si(Q31)(Q32)(Q33), and -N(Q31)(Q32),

    wherein Q31 to Q33 are the same as described above.



    [0070] In one or more embodiments, at least one of R201 to R203 in Formula 201 may be selected from:

    a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and

    a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C1-C10 alkyl group, a phenyl group substituted with -F, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group,

    but embodiments of the present disclosure are not limited thereto.



    [0071] In one or more embodiments, in Formula 202, i) R201 and R202 may be linked via a single bond, and/or ii) R203 and R204 may be linked via a single bond.

    [0072] In one or more embodiments, at least one of R201 to R204 in Formula 202 may be selected from:

    a carbazolyl group; and

    a carbazolyl group substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C1-C10 alkyl group, a phenyl group substituted with -F, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group,

    but embodiments of the present disclosure are not limited thereto.



    [0073] In one or more embodiments, the compound represented by Formula 201 may be represented by Formula 201A:



    [0074] In one or more embodiments, the compound represented by Formula 201 may be represented by Formula 201A(1), but embodiments of the present disclosure are not limited thereto:



    [0075] In one or more embodiments, the compound represented by Formula 201 may be represented by Formula 201A-1, but embodiments of the present disclosure are not limited thereto:



    [0076] In one or more embodiments, the compound represented by Formula 202 may be represented by Formula 202A:





    [0077] In one or more embodiments, the compound represented by Formula 202 may be represented by Formula 202A-1:



    [0078] In Formulae 201A, 201A(1), 201A-1, 202A, and 202A-1,

    L201 to L203, xa1 to xa3, xa5, and R202 to R204 may each be the same as described above,

    R211 and R212 may be understood by referring to the description provided herein in connection with R203, and

    R213 to R217 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C1-C10 alkyl group, a phenyl group substituted with -F, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group.



    [0079] The hole transport region may include at least one compound selected from any of Compounds HT1 to HT39, but embodiments of the present disclosure are not limited thereto:



























    [0080] The hole transport region may have a thickness of about 100 Å to about 10,000 Å, for example, about 100 Å to about 7000 Å, about 100 Å to about 5000 Å, about 100 Å to about 3000 Å, or about 100 Å to about 1,000 Å. When the hole transport region includes at least one of a hole injection layer and a hole transport layer, the hole injection layer may have a thickness of about 100 Å to about 9,000 Å, and for example, about 100 Å to about 7,000 Å, about 100 Å to about 5,000 Å, about 100 Å to about 3,000 Å, about 100 Å to about 1,000 Å or about 500 Å to about 700 Å, and the hole transport layer may have a thickness of about 50 Å to about 2,000 Å, and for example, about 100 Å to about 1,500 Å or about 200 Å to about 400 Å. When the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within these ranges, satisfactory hole transporting characteristics may be obtained without a substantial increase in driving voltage.

    [0081] The emission auxiliary layer may increase the light-emission efficiency of the device by compensating for an optical resonance distance according to the wavelength of light emitted by an emission layer (e.g., by adjusting the optical resonance distance to match the wavelength of light emitted from the emission layer), and the electron blocking layer may block or reduce the flow of electrons from an electron transport region. The emission auxiliary layer and the electron blocking layer may each include the materials as described above.

    [0082] The hole transport region may further include, in addition to these materials, a charge-generation material for the improvement of conductive properties. The charge-generation material may be homogeneously or non-homogeneously dispersed in the hole transport region.

    [0083] The charge-generation material may be, for example, a p-dopant.

    [0084] In one or more embodiments, the p-dopant may have a lowest unoccupied molecular orbital (LUMO) energy level of about -3.5 eV or less.

    [0085] The p-dopant may include at least one selected from a quinone derivative, a metal oxide, and a cyano group-containing compound, but embodiments of the present disclosure are not limited thereto.

    [0086] In one of more embodiments, for example, the p-dopant may include at least one selected from:

    a quinone derivative, such as tetracyanoquinodimethane (TCNQ) and 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane (F4-TCNQ);

    a metal oxide, such as tungsten oxide or molybdenum oxide;

    1,4,5,8,9,11-hexaazatriphenylene-hexacarbonitrile (HAT-CN); and

    a compound represented by Formula 221,

    but embodiments of the present disclosure are not limited thereto:







    [0087] In Formula 221,
    R221 to R223 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C32) aryl group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, wherein at least one selected from R221 to R223 may include at least one substituent selected from a cyano group, -F, -CI, -Br, -I, a C1-C20 alkyl group substituted with -F, a C1-C20 alkyl group substituted with -CI, a C1-C20 alkyl group substituted with -Br, and a C1-C20 alkyl group substituted with -I.

    [0088] When the organic light-emitting device 10 is a full-color organic light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, or a blue emission layer, according to a sub-pixel. In one or more embodiments, the emission layer may have a stacked structure of two or more layers selected from a red emission layer, a green emission layer, and a blue emission layer, in which the two or more layers may contact each other or may be separated from each other. In one or more embodiments, the emission layer may include two or more materials selected from a red light-emitting material, a green light-emitting material, and a blue light-emitting material, in which the two or more materials are mixed with each other in a single layer to emit white light.

    [0089] The emission layer may include a host and a dopant. The dopant may include at least one selected from a phosphorescent dopant and a fluorescent dopant.

    [0090] The dopant may be included in the emission layer in an amount of about 0.01 parts by weight to about 15 parts by weight based on 100 parts by weight of the host, but embodiments of the present disclosure are not limited thereto.

    [0091] The emission layer may have a thickness of about 100 Å to about 1,000 Å, for example, about 100 Å to about 800 Å, about 150 Å to about 800 Å, about 150 Å to about 700 Å, about 150 Å to about 650 Å, about 200 Å to about 600 Å or about 200 Å to about 400 Å. When the thickness of the emission layer is within this range, excellent emission characteristics may be obtained without a substantial increase in driving voltage.

    [0092] In one or more embodiments, the host may include a compound represented by Formula 301:

            Formula 301     [Ar301]xb11-[(L301)xb1-R301]xb21.



    [0093] In Formula 301,

    Ar301 may be a substituted or unsubstituted C5-C60 carbocyclic group or a substituted or unsubstituted C1-C60 heterocyclic group,

    xb11 may be 1, 2, or 3,

    L301 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C1-C60 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group,

    xb1 may be an integer from 0 to 5,

    R301 may be selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C2-C60 alkenyl group, a substituted or unsubstituted C2-C60 alkynyl group, a substituted or unsubstituted C1-C60 alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C6-C60 aryloxy group, a substituted or unsubstituted C6-C60 arylthio group, a substituted or unsubstituted C1-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, - Si(Q301)(Q302)(Q303), -N(Q301)(Q302), -B(Q301)(Q302), -C(=O)(Q301), -S(=O)2(Q301), and - P(=O)(Q301)(Q302), and

    xb21 may be an integer from 1 to 5,

    wherein Q301 to Q303 may each independently be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group, but embodiments of the present disclosure are not limited thereto.



    [0094] For example, Ar301 may be a substituted or unsubstituted C6-C32 carbocyclic group or a substituted or unsubstituted C1-C12 heterocyclic group, but embodiments are not limited thereto.

    [0095] In one or more embodiments, Ar301 in Formula 301 may be selected from:

    a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, and a dibenzothiophene group; and

    a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, and a dibenzothiophene group, each substituted with at least one selected from deuterium, - F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, - Si(Q31)(Q32)(Q33), -N(Q31)(Q32), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) and - P(=O)(Q31)(Q32),

    wherein Q31 to Q33 may each independently be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group. However, embodiments of the present disclosure are not limited thereto.



    [0096] When xb11 in Formula 301 is two or more, two or more Ar301(s) may be linked via a single bond.

    [0097] In one or more embodiments, the compound represented by Formula 301 may be represented by Formula 301-1 or 301-2:







    [0098] In Formulae 301-1 and 301-2,

    A301 to A304 may each independently be selected from a benzene group, a naphthalene group, a phenanthrene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a pyridine group, a pyrimidine group, an indene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, an indole group, a carbazole group, a benzocarbazole group, a dibenzocarbazole group, a furan group, a benzofuran group, a dibenzofuran group, a naphthofuran group, a benzonaphthofuran group, a dinaphthofuran group, a thiophene group, a benzothiophene group, a dibenzothiophene group, a naphthothiophene group, a benzonaphthothiophene group, and a dinaphthothiophene group,

    X301 may be O, S, or N-[(L304)xb4-R304],

    R311 to R314 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group -Si(Q31)(Q32)(Q33), -N(Q31)(Q32), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31), and -P(=O)(Q31)(Q32),

    xb22 and xb23 may each independently be 0, 1, or 2,

    L301, xb1, R301 and Q31 to Q33 may each the same as described above,

    L302 to L304 may each independently be the same as described in connection with L301,

    xb2 to xb4 may each independently be the same as described in connection with xb1, and

    R302 to R304 may each independently be the same as described in connection with R301.



    [0099] For example, L301 to L304 in Formulae 301, 301-1, and 301-2 may each independently be selected from: a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C1-C20 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, but embodiments are not limited thereto.

    [0100] For example, in Formulae 301, 301-1, and 301-2, L301 to L304 may each independently be selected from:

    a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group; and

    a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, -Si(Q31)(Q32)(Q33), -N(Q31)(Q32), - B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31), and -P(=O)(Q31)(Q32),

    wherein Q31 to Q33 are the same as described above.



    [0101] As another example, R301 to R304 in Formulae 301, 301-1, and 301-2 may each independently be selected from: deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C60 (e.g. C1-C10) alkyl group, a substituted or unsubstituted C2-C60 (e.g. C2-C10) alkenyl group, a substituted or unsubstituted C2-C60 (e.g. C2-C10) alkynyl group, a substituted or unsubstituted C1-C60 (e.g. C1-C10) alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, a substituted or unsubstituted C1-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, -Si(Q301)(Q302)(Q303), -N(Q301)(Q302), - B(Q301)(Q302), -C(=O)(Q301), -S(=O)2(Q301), and -P(=O)(Q301)(Q302), but embodiments are not limited thereto.

    [0102] In one or more embodiments, in Formulae 301, 301-1, and 301-2, R301 to R304 may each independently be selected from:

    a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group; and

    a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, -Si(Q31)(Q32)(Q33), -N(Q31)(Q32), - B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) and -P(=O)(Q31)(Q32),

    wherein Q31 and Q33 may be the same as described above.



    [0103] In one or more embodiments, the host may include an alkaline earth metal complex. For example, the host may include a complex selected from a Be complex (for example, Compound H55), a Mg complex, and a Zn complex. For example, the host may be selected from a Be complex (for example, Compound H55) and a Mg complex. In some embodiments, the host may include a Zn complex.

    [0104] In one or more embodiments, the host may include at least one selected from 9,10-di(2-naphthyl)anthracene (ADN), 2-methyl-9,10-bis(naphthalen-2-yl)anthracene (MADN), 9,10-di-(2-naphthyl)-2-t-butyl-anthracene (TBADN), 4,4'-bis(N-carbazolyl)-1,1'-biphenyl (CBP), 1,3-di-9-carbazolylbenzene (mCP), 1,3,5-tri(carbazol-9-yl)benzene (TCP), and any of Compounds H1 to H55, but embodiments of the present disclosure are not limited thereto:































    [0105] The phosphorescent dopant may include an organometallic complex represented by Formula 401 below:

            Formula 401     M(L401)xc1(L402)xc2,





    [0106] In Formulae 401 and 402,

    M may be selected from iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh), and thulium (Tm),

    L401 may be selected from ligands represented by Formula 402, and xc1 may be 1, 2, or 3, wherein, when xc1 is two or more, two or more L401(s) may be identical to or different from each other,

    L402 may be an organic ligand, and xc2 may be an integer from 0 to 4, wherein, when xc2 is two or more, two or more L402(s) may be identical to or different from each other,

    X401 to X404 may each independently be nitrogen (N) or carbon (C),

    X401 and X403 may be linked via a single bond or a double bond, and X402 and X404 may be linked via a single bond or a double bond,

    A401 and A402 may each independently be selected from a C5-C60 (e.g. C5-C30) carbocyclic group or a C1-C60 (e.g. C1-C20) heterocyclic group,

    X405 may be a single bond, *-O-*', *-S-*', *-C(=O)-*', *-N(Q411)-*', *-C(Q411)(Q412)-*', *-C(Q411)=C(Q412)-*', *-C(Q411)=*', or *=C(Q411)=*', wherein Q411 and Q412 may be hydrogen, deuterium, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group,

    X406 may be a single bond, O, or S,

    R401 and R402 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryloxy group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) arylthio group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, -Si(Q401)(Q402)(Q403), -N(Q401)(Q402), -B(Q401)(Q402), -C(=O)(Q401), -S(=O)2(Q401), and -P(=O)(Q401)(Q402), wherein Q401 to Q403 may each independently be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a C6-C20 aryl group, and a C1-C20 heteroaryl group,

    xc11 and xc12 may each independently be an integer selected from 0 to 10, and

    * and *' in Formula 402 each indicate a binding site to M of Formula 401.



    [0107] In one or more embodiments, A401 and A402 in Formula 402 may each independently be selected from a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, an indene group, a pyrrole group, a thiophene group, a furan group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a quinoxaline group, a quinazoline group, a carbazole group, a benzimidazole group, a benzofuran group, a benzothiophene group, an isobenzothiophene group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a dibenzofuran group, and a dibenzothiophene group.

    [0108] In one or more embodiments, in Formula 402, i) X401 may be nitrogen, and X402 may be carbon, or ii) X401 and X402 may each be nitrogen at the same time.

    [0109] In one or more embodiments, in Formula 402, R401 and R402 may each independently be selected from:

    hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, and a C1-C20 alkoxy group;

    a C1-C20 alkyl group, and a C1-C20 alkoxy group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a phenyl group, a naphthyl group, a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, and a norbornenyl group;

    a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group;

    a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and

    -Si(Q401)(Q402)(Q403), -N(Q401)(Q402), -B(Q401)(Q402), -C(=O)(Q401), - S(=O)2(Q401), and -P(=O)(Q401)(Q402),

    wherein Q401 to Q403 may each independently be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, and a naphthyl group, but embodiments of the present disclosure are not limited thereto.



    [0110] In one or more embodiments, when xc1 in Formula 401 is two or more, two A401(s) in two or more L401(s) may optionally be linked via X407, which is a linking group, or two A402(s) in two or more L401(s) may optionally be linked via X408, which is a linking group (see Compounds PD1 to PD4 and PD7). X407 and X408 may each independently be a single bond, *-O-*', *-S-*', *-C(=O)-*', *-N(Q413)-*', *-C(Q413)(Q414)-*', or *-C(Q413)=C(Q414)-*' (wherein Q413 and Q414 may each independently be hydrogen, deuterium, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group), but are not limited thereto.

    [0111] L402 in Formula 401 may be a monovalent, divalent, or trivalent organic ligand. For example, L402 may be selected from halogen, diketone (for example, acetylacetonate), carboxylic acid (for example, picolinate), -C(=O), isonitrile, -CN, and phosphorus (for example, phosphine and phosphite), but embodiments of the present disclosure are not limited thereto.

    [0112] In one or more embodiments, the phosphorescent dopant may be selected from, for example, any of Compounds PD1 to PD25, but embodiments of the present disclosure are not limited thereto:











    [0113] The fluorescent dopant may include an arylamine compound or a styrylamine compound.

    [0114] The fluorescent dopant may include a compound represented by Formula 501:



    [0115] In Formula 501,

    Ar501 may be a substituted or unsubstituted C5-C60 carbocyclic group or a substituted or unsubstituted C1-C60 heterocyclic group,

    L501 to L503 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) arylene group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group,

    xd1 to xd3 may each independently be an integer of 0 to 3,

    R501 and R502 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryl group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) aryloxy group, a substituted or unsubstituted C6-C60 (e.g. C6-C30) arylthio group, a substituted or unsubstituted C1-C60 (e.g. C1-C20) heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and

    xd4 may be an integer of 1 to 6.



    [0116] For example, Ar501 may be a substituted or unsubstituted C5-C30 carbocyclic group or a substituted or unsubstituted C1-C20 heterocyclic group, but embodiments are not limited thereto.

    [0117] In one or more embodiments, Ar501 in Formula 501 may be selected from:

    a naphthalene group, a heptalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, and an indenophenanthrene group; and

    a naphthalene group, a heptalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, and an indenophenanthrene group, each substituted with at least one selected from deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.



    [0118] In one or more embodiments, L501 to L503 in Formula 501 may each independently be selected from:

    a phenylene group, a naphthylene group, a fluorenylene group, a spirobifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group; and

    a phenylene group, a naphthylene group, a fluorenylene group, a spirobifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group, each substituted with at least one selected from deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group.



    [0119] In one or more embodiments, in Formula 501, R501 and R502 may each independently be selected from:

    a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group; and

    a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group, each substituted with at least one selected from deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, and - Si(Q31)(Q32)(Q33),

    wherein Q31 to Q33 may each be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.



    [0120] In one or more embodiments, xd4 in Formula 501 may be 2, but embodiments of the present disclosure are not limited thereto.

    [0121] In one or more embodiments, for example, the fluorescent dopant may be selected from any of Compounds FD1 to FD22:



















    [0122] In one or more embodiments, the fluorescent dopant may be selected from the following compounds, but embodiments of the present disclosure are not limited thereto:







    [0123] The electron transport region may have: i) a single-layered structure including a single layer including a single material, ii) a single-layered structure including a single layer including a plurality of different materials, or iii) a multi-layered structure having a plurality of layers including a plurality of different materials.

    [0124] The electron transport region may include at least one selected from a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, and an electron injection layer, but embodiments of the present disclosure are not limited thereto.

    [0125] For example, the electron transport region may have an electron transport layer/electron injection layer structure, a hole blocking layer/electron transport layer/electron injection layer structure, an electron control layer/electron transport layer/electron injection layer structure, or a buffer layer/electron transport layer/electron injection layer structure, wherein the constituting layers of each structure are sequentially stacked from an emission layer. However, embodiments of the structure of the electron transport region are not limited thereto.

    [0126] The electron transport region (for example, a buffer layer, a hole blocking layer, an electron control layer, or an electron transport layer in the electron transport region) may include a metal-free compound containing at least one π electron-depleted nitrogen-containing ring.

    [0127] As used herein, the term "π electron-depleted nitrogen-containing ring" may refer to a C1-C60 (e.g. a C1-C30) heterocyclic group having at least one *-N=*' moiety as a ring-forming moiety.

    [0128] For example, the "π electron-depleted nitrogen-containing ring" may be: i) a 5-membered to 7-membered heteromonocyclic group having at least one *-N=*' moiety, ii) a heteropolycyclic group in which two or more 5-membered to 7-membered heteromonocyclic groups each having at least one *-N=*' moiety are condensed with each other, or iii) a heteropolycyclic group in which at least one of 5-membered to 7-membered heteromonocyclic groups, each having at least one *-N=*' moiety, is condensed with at least one C5-C60 (e.g. a C5-C30) carbocyclic group.

    [0129] Non-limiting examples of the π electron-depleted nitrogen-containing ring may include an imidazole, a pyrazole, a thiazole, an isothiazole, an oxazole, an isoxazole, a pyridine, a pyrazine, a pyrimidine, a pyridazine, an indazole, a purine, a quinoline, an isoquinoline, a benzoquinoline, a phthalazine, a naphthyridine, a quinoxaline, a quinazoline, a cinnoline, a phenanthridine, an acridine, a phenanthroline, a phenazine, a benzimidazole, an isobenzothiazole, a benzoxazole, an isobenzoxazole, a triazole, a tetrazole, an oxadiazole, a triazine, a thiadiazole, an imidazopyridine, an imidazopyrimidine, and an azacarbazole.

    [0130] In one or more embodiments, for example, the electron transport region may include a compound represented by Formula 601:

            Formula 601     [Ar601]xe11-[(L601)xe1-R601]xe21 .



    [0131] In Formula 601,

    Ar601 may be a substituted or unsubstituted C5-C60 carbocyclic group or a substituted or unsubstituted C1-C60 heterocyclic group,

    xe11 may be 1, 2, or 3,

    L601 may each independently be selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C1-C60 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group;

    xe1 may be an integer from 0 to 5,

    R601 may be selected from a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C6-C60 aryloxy group, a substituted or unsubstituted C6-C60 arylthio group, a substituted or unsubstituted C1-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, - Si(Q601)(Q602)(Q603), -C(=O)(Q601), -S(=O)2(Q601), and -P(=O)(Q601)(Q602),

    wherein Q601 to Q603 may each independently be a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group, and

    xe21 may be an integer from 1 to 5.



    [0132] In one or more embodiments, at least one of Ar601(s) in the number of xe11 and/or at least one of R601(s) in the number of xe21 may include the π electron-depleted nitrogen-containing ring.

    [0133] For example, Ar601 may be a substituted or unsubstituted C5-C30 carbocyclic group or a substituted or unsubstituted C1-C20 heterocyclic group, but embodiments are not limited thereto.

    [0134] In one or more embodiments, ring Ar601 in Formula 601 may be selected from:

    a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an iso-benzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group; and

    a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an iso-benzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, -Si(Q31)(Q32)(Q33), -S(=O)2(Q31), and -P(=O)(Q31)(Q32),

    wherein Q31 to Q33 may each independently be selected from a C1-C10 alkyl group, a C1-C10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.



    [0135] When xe11 in Formula 601 is two or more, two or more Ar601(s) may be linked via a single bond.

    [0136] In one or more embodiments, Ar601 in Formula 601 may be an anthracene group.

    [0137] In one or more embodiments, a compound represented by Formula 601 may be represented by Formula 601-1:



    [0138] In Formula 601-1,

    X614 may be N or C(R614), X615 may be N or C(R615), X616 may be N or C(R616), and at least one selected from X614 to X616 may be N,

    L611 to L613 may each independently be the same as described in connection with L601,

    xe611 to xe613 may each independently be the same as described in connection with xe1,

    R611 to R613 may each independently be the same as described in connection with R601,

    R614 to R616 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.



    [0139] For example, L601 and L611 to L613 in Formulae 601 and 601-1 may each independently be selected from: a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C1-C10 heterocycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C1-C10 heterocycloalkenylene group, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C1-C20 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, but embodiments are not limited thereto.

    [0140] In one or more embodiments, L601 and L611 to L613 in Formulae 601 and 601 - 1 may each independently be selected from:

    a phenylene group, a naphthylene group, a fluorenylene group, a spirobifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group; and

    a phenylene group, a naphthylene group, a fluorenylene group, a spirobifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group, but embodiments of the present disclosure are not limited thereto.



    [0141] In one or more embodiments, xe1 and xe611 to xe613 in Formulae 601 and 601-1 may each independently be 0, 1, or 2.

    [0142] For example, R601 and R611 to R613 in Formulae 601 and 601-1 may each independently be selected from: a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, a substituted or unsubstituted C1-C20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, - Si(Q601)(Q602)(Q603), -C(=O)(Q601), -S(=O)2(Q601), and -P(=O)(Q601)(Q602).

    [0143] In one or more embodiments, R601 and R611 to R613 in Formula 601 and 601 - 1 may each independently be selected from:

    a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group;

    a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group; and

    -S(=O)2(Q601) and -P(=O)(O601)(O602),

    wherein Q601 and Q602 may be the same as described above.



    [0144] The electron transport region may include at least one compound selected from any of Compounds ET1 to ET36, but embodiments of the present disclosure are not limited thereto:

























    [0145] In one or more embodiments, the electron transport region may include at least one selected from 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 4,7-diphenyl-1,10-phenanthroline (Bphen), Alq3, BAlq, 3-(biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole (TAZ), and NTAZ:





    [0146] The buffer layer, the hole blocking layer, and/or the electron controlling layer may each independently have a thickness of about 20 Å to about 1,000 Å, for example, about 20 Å to about 700 Å, about 20 Å to about 500 Å, about 20 Å to about 400, about 30 Å to about 400 Å or about 30 Å to about 300 Å. When the thicknesses of the buffer layer, the hole blocking layer, and the electron control layer are within these ranges, the electron blocking layer may have excellent electron blocking characteristics or electron control characteristics without a substantial increase in driving voltage.

    [0147] The electron transport layer may have a thickness of about 100 Å to about 1,000 Å, for example, about 100 Å to about 700 Å, about 100 Å to about 600 Å. about 150 Å to about 600 Å, about 150 Å to about 500 Å or about 250 Å to about 350 Å. When the thickness of the electron transport layer is within these ranges, the electron transport layer may have satisfactory electron transport characteristics without a substantial increase in driving voltage.

    [0148] The electron transport region (for example, the electron transport layer in the electron transport region) may further include, in addition to the materials described above, a metal-containing material.

    [0149] The metal-containing material may include at least one selected from an alkali metal complex and an alkaline earth-metal complex. The alkali metal complex may include a metal ion selected from a lithium (Li) ion, a sodium (Na) ion, a potassium (K) ion, a rubidium (Rb) ion, and a cesium (Cs) ion, and the alkaline earth-metal complex may include a metal ion selected from a beryllium (Be) ion, a magnesium (Mg) ion, a calcium (Ca) ion, a strontium (Sr) ion, and a barium (Ba) ion. The alkali metal complex may include a ligand coordinated with the metal ion of the alkali metal complex or the alkaline earth-metal complex, and the ligand may be selected from a hydroxy quinoline, a hydroxy isoquinoline, a hydroxy benzoquinoline, a hydroxy acridine, a hydroxy phenanthridine, a hydroxy phenyloxazole, a hydroxy phenylthiazole, a hydroxy diphenyloxadiazole, a hydroxy diphenylthiadiazole, a hydroxy phenylpyridine, a hydroxy phenylbenzimidazole, a hydroxy phenylbenzothiazole, a bipyridine, a phenanthroline, and a cyclopentadiene, but embodiments of the present disclosure are not limited thereto.

    [0150] For example, the metal-containing material may include a Li complex. The Li complex may include, for example, Compound ET-D1 (lithium quinolate, LiQ) or ET-D2:



    [0151] The electron transport region may include an electron injection layer that facilitates injection of electrons from the second electrode 190. The electron injection layer may directly contact the second electrode 190.

    [0152] The electron injection layer may have: i) a single-layered structure including a single layer including a single material, ii) a single-layered structure including a single layer including a plurality of different materials, or iii) a multi-layered structure having a plurality of layers including a plurality of different materials.

    [0153] The electron injection layer may include an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth-metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth-metal complex, a rare earth metal complex, or any combination thereof.

    [0154] The alkali metal may be selected from Li, Na, K, Rb, and Cs. In one or more embodiments, the alkali metal may be Li, Na, or Cs. In one or more embodiments, the alkali metal may be Li or Cs, but embodiments of the present disclosure are not limited thereto.

    [0155] The alkaline earth metal may be selected from Mg, Ca, Sr, and Ba.

    [0156] The rare earth metal may be selected from scandium (Sc), yttrium (Y), cerium (Ce), terbium (Tb), ytterbium (Yb), and gadolinium (Gd).

    [0157] The alkali metal compound, the alkaline earth-metal compound, and the rare earth metal compound may be selected from oxides and halides (for example, fluorides, chlorides, bromides, or iodides) of the alkali metal, the alkaline earth-metal, and the rare earth metal.

    [0158] The alkali metal compound may be selected from alkali metal oxides (such as Li2O, Cs2O, or K2O) and alkali metal halides (such as LiF, NaF, CsF, KF, LiI, Nal, CsI, or Kl). In one or more embodiments, the alkali metal compound may be selected from LiF, Li2O, NaF, Lil, Nal, Csl, and Kl, but embodiments of the present disclosure are not limited thereto.

    [0159] The alkaline earth-metal compound may be selected from alkaline earth-metal oxides (such as BaO, SrO, CaO, BaxSr1-xO (0<x<1), or BaxCa1-xO (0<x<1)). In one or more embodiments, the alkaline earth-metal compound may be selected from BaO, SrO, and CaO, but embodiments of the present disclosure are not limited thereto.

    [0160] The rare earth metal compound may be selected from YbF3, ScF3, ScO3, Y2O3, Ce2O3, GdF3, and TbF3. In one or more embodiments, the rare earth metal compound may be selected from YbF3, ScF3, TbF3, YbI3, ScI3, and TbI3, but embodiments of the present disclosure are not limited thereto.

    [0161] The alkali metal complex, the alkaline earth-metal complex, and the rare earth metal complex may respectively include an alkali metal ion, alkaline earth-metal ion, and rare earth metal ion as described above. The ligand coordinated with the metal ion in the alkali metal complex, the alkaline earth-metal complex, or the rare earth metal complex may be selected from hydroxy quinoline, hydroxy isoquinoline, hydroxy benzoquinoline, hydroxy acridine, hydroxy phenanthridine, hydroxy phenyloxazole, hydroxy phenylthiazole, hydroxy diphenyloxadiazole, hydroxy diphenylthiadiazole, hydroxy phenylpyridine, hydroxy phenylbenzimidazole, hydroxy phenylbenzothiazole, bipyridine, phenanthroline, and cyclopentadiene, but embodiments of the present disclosure are not limited thereto.

    [0162] The electron injection layer may include (e.g., may consist of) an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth-metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth-metal complex, a rare earth metal complex, or any combination thereof, as described above. In one or more embodiments, the electron injection layer may further include an organic material. When the electron injection layer further includes an organic material, the alkali metal, alkaline earth metal, rare earth metal, alkali metal compound, alkaline earth-metal compound, rare earth metal compound, alkali metal complex, alkaline earth-metal complex, rare earth metal complex, or combination thereof may be homogeneously or non-homogeneously dispersed in a matrix including the organic material.

    [0163] The electron injection layer may have a thickness of about 1 Å to about 100 Å, for example, about 1 Å to about 95 Å, about 2 Å to about 95 Å or about 3 Å to about 90 Å. When the thickness of the electron injection layer is within the range described above, the electron injection layer may have satisfactory electron injection characteristics without a substantial increase in driving voltage.

    [0164] The second electrode 190 may be positioned on the organic layer 150 having the above-described structure. The second electrode 190 may be a cathode that is an electron injection electrode, and in this regard, the material for forming the second electrode 190 may be a material having a low work function, and may include a metal, an alloy, an electrically conductive compound, or a combination thereof.

    [0165] In one or more embodiments, the second electrode 190 may include at least one selected from lithium (Li), silver (Si), magnesium (Mg), aluminium (Al), aluminium-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), ITO, and IZO, but embodiments of the present disclosure are not limited thereto. The second electrode 190 may be a transmissive electrode, a semi-transmissive electrode, or a reflective electrode.

    [0166] The second electrode 190 may have a single-layered structure, or a multi-layered structure including two or more layers.

    [0167] An organic light-emitting device 20 as illustrated in FIG. 2 includes a first capping layer 210, a first electrode 110, an organic layer 150, and a second electrode 190 sequentially stacked in this stated order. An organic light-emitting device 30 as illustrated in FIG. 3 includes a first electrode 110, an organic layer 150, a second electrode 190, and a second capping layer 220 sequentially stacked in this stated order. An organic light-emitting device 40 as illustrated in FIG. 4 includes a first capping layer 210, a first electrode 110, an organic layer 150, a second electrode 190, and a second capping layer 220 sequentially stacked in this stated order.

    [0168] In FIGS. 2 to 4, the first electrode 110, the organic layer 150, and the second electrode 190 may be understood by referring to the description presented in connection with FIG. 1.

    [0169] In the organic layer 150 of each of the organic light-emitting devices 20 and 40, light generated in the emission layer may pass through the first electrode 110 (which is a semi-transmissive or transmissive electrode) and the first capping layer 210 toward the outside. In the organic layer 150 of each of the organic light-emitting devices 30 and 40, light generated in the emission layer may pass through the second electrode 190 (which is a semi-transmissive or transmissive electrode) and the second capping layer 220 toward the outside.

    [0170] The first capping layer 210 and the second capping layer 220 may increase the external luminescent efficiency of the device according to the principle of constructive interference.

    [0171] The first capping layer 210 and the second capping layer 220 may each independently be an organic capping layer including an organic material, an inorganic capping layer including an inorganic material, or a composite capping layer including an organic material and an inorganic material.

    [0172] At least one selected from the first capping layer 210 and the second capping layer 220 may include at least one material selected from carbocyclic compounds, heterocyclic compounds, amine-based compounds, porphyrin derivatives, phthalocyanine derivatives, a naphthalocyanine derivatives, alkali metal complexes, and alkaline earth-based complexes. The carbocyclic compound, the heterocyclic compound, and the amine-based compound may be optionally substituted with a substituent containing at least one element selected from O, N, S, selenium (Se), silicon (Si), fluorine (F), chlorine (CI), bromine (Br), and iodine (I). In one or more embodiments, at least one selected from the first capping layer 210 and the second capping layer 220 may include an amine-based compound.

    [0173] In one or more embodiments, at least one selected from the first capping layer 210 and the second capping layer 220 may include the compound represented by Formula 201 or the compound represented by Formula 202.

    [0174] In one or more embodiments, at least one selected from the first capping layer 210 and the second capping layer 220 may include a compound selected from any of Compounds HT28 to HT33 and Compounds CP1 to CP5, but embodiments of the present disclosure are not limited thereto:





    [0175] The organic light-emitting device according to embodiments of the present disclosure has been described in connection with FIGS. 1 to 4. However, embodiments of the present disclosure are not limited thereto.

    [0176] The layers constituting the hole transport region, the emission layer, and the layers constituting the electron transport region may each be formed in a set or predetermined region (e.g., position) using one or more suitable methods selected from vacuum deposition, spin coating, casting, Langmuir-Blodgett (LB) deposition, ink-jet printing, laser-printing, and laser-induced thermal imaging.

    [0177] When the layers constituting the hole transport region, the emission layer, and the layers constituting the electron transport region are formed by vacuum deposition, for example, the vacuum deposition may be performed at a deposition temperature of about 100 to about 500°C, at a vacuum degree of about 10-8 Torr to about 10-3 Torr, and at a deposition rate of about 0.01 Å/sec to about 100 Å/sec depending on the material to be included in each layer, and the intended structure of each layer.

    [0178] When the layers constituting the hole transport region, the emission layer, and the layers constituting the electron transport region are formed by spin coating, the spin coating may be performed at a coating speed of about 2,000 rpm to about 5,000 rpm and at a heat treatment temperature of about 80°C to about 200°C, depending on the material to be included in each layer and the intended structure of each layer.

    [0179] The term "C1-C60 alkyl group" as used herein refers to a linear or branched saturated aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms, and non-limiting examples thereof may include a methyl group, an ethyl group, a propyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an isoamyl group, and a hexyl group. The term "C1-C60 alkylene group" as used herein refers to a divalent group having substantially the same structure as the C1-C60 alkyl group. Corresponding definitions apply to other ranges given for the number of carbon atoms in an alkyl/alkylene group.

    [0180] The term "C2-C60 alkenyl group" as used herein refers to a hydrocarbon group formed by substituting at least one carbon-carbon double bond in the middle or at the terminus of the C2-C60 alkyl group, and non-limiting examples thereof may include an ethenyl group, a propenyl group, and a butenyl group. The term "C2-C60 alkenylene group" as used herein refers to a divalent group having substantially the same structure as the C2-C60 alkenyl group. Corresponding definitions apply to other ranges given for the number of carbon atoms in an alkenyl/alkenylene group.

    [0181] The term "C2-C60 alkynyl group" as used herein refers to a hydrocarbon group formed by substituting at least one carbon-carbon triple bond in the middle or at the terminus of the C2-C60 alkyl group, and non-limiting examples thereof may include an ethynyl group and a propynyl group. The term "C2-C60 alkynylene group" as used herein refers to a divalent group having substantially the same structure as the C2-C60 alkynyl group. Corresponding definitions apply to other ranges given for the number of carbon atoms in an alkynyl/alkynylene group.

    [0182] The term "C1-C60 alkoxy group" as used herein refers to a monovalent group represented by -O-A101 (wherein A101 is a C1-C60 alkyl group), and non-limiting examples thereof may include a methoxy group, an ethoxy group, and an isopropyloxy group. Corresponding definitions apply to other ranges given for the number of carbon atoms in an alkoxy group.

    [0183] The term "C3-C10 cycloalkyl group" as used herein refers to a monovalent saturated hydrocarbon monocyclic group having 3 to 10 carbon atoms, and non-limiting examples thereof may include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group. The term "C3-C10 cycloalkylene group" as used herein refers to a divalent group having substantially the same structure as the C3-C10 cycloalkyl group.

    [0184] The term "C1-C10 heterocycloalkyl group" as used herein refers to a monovalent saturated monocyclic group having at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom and 1 to 10 carbon atoms, and non-limiting examples thereof may include a 1,2,3,4-oxatriazolidinyl group, a tetrahydrofuranyl group, a tetrahydrothiophenyl group. The term "C1-C10 heterocycloalkylene group" as used herein refers to a divalent group having substantially the same structure as the C1-C10 heterocycloalkyl group.

    [0185] The term "C3-C10 cycloalkenyl group" as used herein refers to a monovalent monocyclic group that has 3 to 10 carbon atoms, at least one carbon-carbon double bond in the ring thereof, and no aromaticity, and non-limiting examples thereof may include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. The term "C3-C10 cycloalkenylene group" as used herein refers to a divalent group having substantially the same structure as the C3-C10 cycloalkenyl group.

    [0186] The term "C1-C10 heterocycloalkenyl group" as used herein refers to a monovalent monocyclic group that has at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, 1 to 10 carbon atoms, and at least one carbon-carbon double bond in its ring. Non-limiting examples of the C1-C10 heterocycloalkenyl group may include a 4,5-dihydro-1,2,3,4-oxatriazolyl group, a 2,3-dihydrofuranyl group, and a 2,3-dihydrothiophenyl group. The term "C1-C10 heterocycloalkenylene group" as used herein refers to a divalent group having substantially the same structure as the C1-C10 heterocycloalkenyl group.

    [0187] The term "C6-C60 aryl group" as used herein refers to a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms, and the term "C6-C60 arylene group" as used herein refers to a divalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. Non-limiting examples of the C6-C60 aryl group may include a phenyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, and a chrysenyl group. When the C6-C60 aryl group and the C6-C60 arylene group each include two or more rings, the rings may be fused to each other. Corresponding definitions apply to other ranges given for the number of carbon atoms in an aryl/arylene group.

    [0188] The term "C1-C60 heteroaryl group" as used herein refers to a monovalent group having a heterocyclic aromatic system that has at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, in addition to 1 to 60 carbon atoms. The term "C1-C60 heteroarylene group" as used herein refers to a divalent group having a heterocyclic aromatic system that has at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, in addition to 1 to 60 carbon atoms. Non-limiting examples of the C1-C60 heteroaryl group include a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, and an isoquinolinyl group. When the C1-C60 heteroaryl group and the C1-C60 heteroarylene group each include two or more rings, the rings may be fused to each other. Corresponding definitions apply to other ranges given for the number of carbon atoms in an heteroaryl/heteroarylene group.

    [0189] The term "C6-C60 aryloxy group" as used herein refers to -O-A102 (wherein A102 is a C6-C60 aryl group), and the term "C6-C60 arylthio group" as used herein refers to -S-A103 (wherein A103 is a C6-C60 aryl group). Corresponding definitions apply to other ranges given for the number of carbon atoms in an aryloxy group and an arylthio group.

    [0190] The term "monovalent non-aromatic condensed polycyclic group" as used herein refers to a monovalent group (for example, having 8 to 60 carbon atoms) having two or more rings condensed with each other, only carbon atoms as ring-forming atoms, and no aromaticity in its entire molecular structure. A non-limiting example of the monovalent non-aromatic condensed polycyclic group is a fluorenyl group. The term "divalent non-aromatic condensed polycyclic group" as used herein refers to a divalent group having substantially the same structure as the monovalent non-aromatic condensed polycyclic group.

    [0191] The term "monovalent non-aromatic condensed heteropolycyclic group" as used herein refers to a monovalent group (for example, having 1 to 60 carbon atoms) having two or more rings condensed to each other, at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, and no aromaticity in its entire molecular structure. A non-limiting example of the monovalent non-aromatic condensed heteropolycyclic group is a carbazolyl group. The term "divalent non-aromatic condensed heteropolycyclic group" as used herein refers to a divalent group having the same structure as the monovalent non-aromatic condensed heteropolycyclic group.

    [0192] The term "C5-C60 carbocyclic group" as used herein refers to a monocyclic or polycyclic group having 5 to 60 carbon atoms, in which the ring-forming atoms are only carbon atoms. The C5-C60 carbocyclic group may be an aromatic carbocyclic group or a non-aromatic carbocyclic group. The C5-C60 carbocyclic group may be a ring, such as benzene, a monovalent group, such as a phenyl group, or a divalent group, such as a phenylene group. In one or more embodiments, depending on the number of substituents connected to the C5-C60 carbocyclic group, the C5-C60 carbocyclic group may be a trivalent group or a quadrivalent group. Corresponding definitions apply to other ranges given for the number of carbon atoms in a carbocyclic group.

    [0193] The term "C1-C60 heterocyclic group" as used herein refers to a group having substantially the same structure as the C1-C60 carbocyclic group, except that at least one heteroatom selected from N, O, Si, P, and S may be used as a ring-forming atom in addition to carbon (the number of carbon atoms may be in a range of 1 to 60). Corresponding definitions apply to other ranges given for the number of carbon atoms in a heterocyclic group.

    [0194] At least one substituent of the substituted C5-C60 carbocyclic group, the substituted C1-C60 heterocyclic group, the substituted C3-C10 cycloalkylene group, the substituted C1-C10 heterocycloalkylene group, the substituted C3-C10 cycloalkenylene group, the substituted C1-C10 heterocycloalkenylene group, the substituted C6-C60 arylene group, the substituted C1-C60 heteroarylene group, the substituted divalent non-aromatic condensed polycyclic group, the substituted divalent non-aromatic condensed heteropolycyclic group, the substituted C1-C60 alkyl group, the substituted C2-C60 alkenyl group, the substituted C2-C60 alkynyl group, the substituted C1-C60 alkoxy group, the substituted C3-C10 cycloalkyl group, the substituted C1-C10 heterocycloalkyl group, the substituted C3-C10 cycloalkenyl group, the substituted C1-C10 heterocycloalkenyl group, the substituted C6-C60 aryl group, the substituted C6-C60 aryloxy group, the substituted C6-C60 arylthio group, the substituted C1-C60 heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group, when present, may be selected from:

    deuterium (-D), -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group;

    a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group, each substituted with at least one selected from deuterium, -F, - Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q11)(Q12)(Q13), - N(Q11)(Q12), -B(Q11)(Q12), -C(=O)(O11), -S(=O)2(Q11), and -P(=O)(Q11)(Q12);

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q21)(Q22)(Q23), - N(Q21)(Q22), -B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21), and -P(=O)(Q21)(Q22); and

    -Si(Q31)(Q32)(Q33), -N(Q31)(Q32), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31), and -P(=O)(Q31)(Q32),

    wherein Q11 to Q13, Q21 to Q23, and Q31 to Q33 may each independently be selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group.



    [0195] The term "Ph", as used herein, may refer to a phenyl group; the term "Me", as used herein, may refer to a methyl group; the term "Et", as used herein, may refer to an ethyl group; the terms "ter-Bu" or "But", as used herein, may refer to a tert-butyl group; and the term "OMe" as used herein may refer to a methoxy group.

    [0196] The term "biphenyl group" as used herein refers to "a phenyl group substituted with a phenyl group." In other words, the "biphenyl group" is a substituted phenyl group having a phenyl group as a substituent.

    [0197] The term "terphenyl group" as used herein refers to "a phenyl group substituted with a biphenyl group." In other words, the "terphenyl group" is a phenyl group having, as a substituent, a phenyl group substituted with a phenyl group.

    [0198] * and *' used herein, unless defined otherwise, each refer to a binding site to a neighboring atom in a corresponding formula.

    [0199] Hereinafter, a compound according to examples of the present disclosure and an organic light-emitting device according to embodiments of the present disclosure will be described in more detail with reference to Synthesis Examples and Examples. The wording "B was used instead of A" used in describing Synthesis Examples indicates that an identical molar equivalent of B was used in place of A.

    [Synthesis Example]


    Synthesis Example 1: Synthesis of Compound 2



    [0200] 


    (1) Synthesis of Intermediate 2-3



    [0201] 10 g of methyl 5-bromo-2-iodobenzoate (2-1) and 5 g of naphthalene-1-boronic acid (2-2) were dissolved in 100 mL of tetrahydrofuran (THF) and 25 mL of water, and 1 g of Pd(PPh3)4 and 12 g of K2CO3 were added dropwise thereto. The reaction vessel was stirred under reflux at a temperature of 65°C for 6 hours. After the reaction vessel was cooled to room temperature, the THF was removed under reduced pressure, and the mixture was extracted three times using ethyl acetate. The organic solution was dried over magnesium sulfate and filtered under reduced pressure. The residue obtained therefrom was purified by column chromatography to obtain 8.3 g (yield: 83%) of Intermediate 2-3.

    [0202] C18H13BrO2 M+1: 341.01.

    (2) Synthesis of Intermediate 2-4



    [0203] 8.3 g of Intermediate 2-3 was dissolved in 120 mL of THF, and 60 mL of PhMgBr (1M) was slowly added dropwise thereto at a temperature of 0°C. The mixture was slowly allowed to warm to room temperature and stirred for 16 hours. The reaction was then cooled to a temperature of 0°C and terminated by addition of a saturated ammonium chloride aqueous solution. The reaction was extracted three times using ethyl acetate. The organic solution was dried over magnesium sulfate and filtered under reduced pressure. Then, the residue obtained therefrom was purified by column chromatography to obtain 7.7 g (yield: 68%) of Intermediate 2-4.

    [0204] C29H21BrO M+1: 465.08.

    (3) Synthesis of Intermediate 2-5



    [0205] 7.7 g of Intermediate 2-4 was dissolved in 80 mL of dichloromethane, and 0.5 mL of methanesulfonic acid was added thereto and stirred for 3 hours. The reaction was terminated by addition of 1 mL of triethylamine, and filtered under reduced pressure. Then, the residue obtained therefrom was purified by column chromatography to obtain 7.0 g (yield: 95%) of Intermediate 2-5.

    [0206] C29H19Br M+1: 447.07.

    (4) Synthesis of Compound 2



    [0207] 3 g of Intermediate 2-5, 3 g of N-phenyl-[1,1'-biphenyl]-4-amine, 0.34 g of Pd2(dba)3, 0.1 mL of PtBu3, and 3.6 g of KOtBu were dissolved in 60 mL of toluene and stirred at a temperature of 85°C for 2 hours. The reaction solution was cooled to room temperature, and the reaction was terminated by water. The reaction was extracted three times using ethyl acetate. The organic solution was dried over magnesium sulfate and distilled under reduced pressure. Then, the residue obtained therefrom was separated and purified by silica gel column chromatography to obtain 3.7 g (yield: 90%) of Compound 2.

    [0208] C47H33N M+1: 612.26.

    [0209] 1H NMR (500 MHz, CDCl3) δ= 7.72-7.50(m, 6H), 7.48-7.38(m, 5H), 7.25-6.94(m, 16H), 6.77(td, 1H), 6.55(dt, 1H), 6.09(m, 1H), 6.05(m, 2H), 6.00(dd, 1H).

    Synthesis Example 2: Synthesis of Compound 10



    [0210] 



    [0211] 3.2 g (yield: 78%) of Compound 10 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of N-phenyl-[1,1'-biphenyl]-2-amine was used instead of N-phenyl-[1,1'-biphenyl]-4-amine.

    [0212] C47H33N M+1: 612.26.

    [0213] 1H NMR (500 MHz, CDCl3) δ= 7.72-7.50(m, 6H), 7.48-7.43(m, 4H), 7.32(dt, 1H), 7.25-6.94(m, 16H), 6.77(td, 1H), 6.55(dt, 1H), 6.09(m, 1H), 6.05(m, 2H), 6.00(dd, 1H).

    Synthesis Example 3: Synthesis of Compound 11



    [0214] 



    [0215] 3.4 g (yield: 81%) of Compound 11 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of N-phenyldibenzo[b,d]furan-1-amine was used instead of N-phenyl-[1,1'-biphenyl]-4-amine.

    [0216] C47H31NO M+1: 626.24.

    [0217] 1H NMR (500 MHz, CDCl3) δ= 7.79(m, 1H), 7.72-7.60(m, 5H), 7.49-7.44(m, 2H), 7.33-7.25(m, 4H), 7.22-7.16(m, 4H), 7.15-6.99(m, 9H), 6.67(dd, 1H), 6.61(dt, 1H), 6.63(dd, 1H), 6.26(m, 3H).

    Synthesis Example 4: Synthesis of Compound 16



    [0218] 



    [0219] 3.0 g (yield: 69%) of Compound 16 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of 9,9-dimethyl-N-phenyl-9H-fluoren-2-amine (16-1) was used instead of N-phenyl-[1,1'-biphenyl]-4-amine, and 3 g of Intermediate 16-2 was used instead of Intermediate 2-5.

    [0220] C50H37N M+1: 651.29.

    [0221] 1H NMR (500 MHz, CDCl3) δ= 7.81(dd, 1H), 7.75(dd, 1H), 7.62(s, 1H), 7.55-7.52(m, 2H), 7.47-7.41 (m, 2H), 7.36-7. 25(m, 2H), 7.23-6.93(m, 16H), 6.82(td, 1H), 6.65-6.60(m, 2 H), 6.36(d, 1H), 6.11(m, 2H), 1.61(s, 6H).

    Synthesis Example 5: Synthesis of Compound 21



    [0222] 



    [0223] 2.7 g (yield: 60%) of Compound 21 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of N-([1,1'-biphenyl]-4-yl)naphthalen-2-amine was used instead of N-phenyl-[1,1'-biphenyl]-4-amine, and 3 g of Intermediate 16-2 was used instead of Intermediate 2-5.

    [0224] C51H35N M+1: 662.28.

    [0225] 1H NMR (500 MHz, CDCl3) δ= 7.81-7.75(m, 2H), 7.70(m, 1H), 7.66-7.60(m, 3H),7.59-7.34(m, 13H), 7.28-7.05(m, 12H)., 6.99(dt, 1H), 6.84-6.74(m, 4H).

    Synthesis Example 6: Synthesis of Compound 34



    [0226] 


    (1) Synthesis of Intermediate 34-2



    [0227] 8 g (yield: 85%) of Intermediate 34-2 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-3, except that 5 g of (4-fluoronaphthalen-1-yl)boronic acid (34-1) was used instead of naphthalene-1-boronic acid.

    [0228] C18H12BrFO2 M+1: 359.00.

    (2) Synthesis of Intermediate 34-3



    [0229] 8 g (yield: 74%) of Intermediate 34-3 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-4, except that 8 g of Intermediate 34-2 was used instead of Intermediate 2-3.

    [0230] C29H20BrFO M+1: 483.07.

    (3) Synthesis of Intermediate 34-4



    [0231] 6.5 g (yield: 84%) of Intermediate 34-4 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-5, except that 8 g of Intermediate 34-3 was used instead of Intermediate 2-4.

    [0232] C29H18BrF M+1: 465.06.

    (4) Synthesis of Compound 34



    [0233] 3.4 g (yield: 84%) of Compound 34 was obtained in substantially the same manner as in the Synthesis of Compound 10, except that 3 g of Intermediate 34-4 was used instead of Intermediate 2-5.

    [0234] C47H32FN M+1: 630.25.

    [0235] 1H NMR (500 MHz, CDCl3) δ= 7.76-7.70(m, 2H), 7.62-7.53(m, 3H), 7.50-7.44(m, 3H), 7.37-7.30(m, 5H), 7.25-6.95(m, 13H), 6.77(dd, 1H), 6.65(dt, 1H), 6.18(d, 1H), 6.06(m, 3H).

    Synthesis Example 7: Synthesis of Compound 38



    [0236] 


    (1) Synthesis of Intermediate 38-3



    [0237] 12 g (yield: 80%) of Intermediate 38-3 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-3, except that 10 g of (4-bromonaphthalen-1-yl)boronic acid (38-2) was used instead of naphthalene-1-boronic acid and 9.5 grams of methyl 6-bromo-3-fluorobenzoate (38-1) was used instead of methyl 5-bromo-2-iodobenzoate (2-1).

    [0238] C18H12BrFO2 M+1: 359.00.

    (2) Synthesis of Intermediate 38-4



    [0239] 14 g (yield: 87%) of Intermediate 38-4 was obtained in substantially the same manner as in the Synthesis of Compound 2-4, except that 12 g of Intermediate 38-3 was used instead of Intermediate 2-3.

    [0240] C29H20BrFO M+1: 483.07.

    (3) Synthesis of Intermediate 38-5



    [0241] 8 g (yield: 59%) of Intermediate 38-5 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-5, except that 14 g of Intermediate 38-4 was used instead of Intermediate 2-4.

    [0242] C29H18BrF M+1: 465.06.

    (4) Synthesis of Compound 38



    [0243] 3.1 g (yield: 60%) of Compound 38 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of Intermediate 38-5 was used instead of Intermediate 2-5.

    [0244] C47H32FN M+1: 630.25.

    [0245] 1H NMR (500 MHz, CDCl3) δ= 7.77(m, 1H), 7.65-7.60(m, 2H), 7.55-7.28(m, 11H), 7.22-6.94(m, 12H), 6.78(m, 2H), 6.65(dt, 1H), 6.43(dd, 1H), 6.12(m, 2H).

    Synthesis Example 8: Synthesis of Compound 54



    [0246] 


    (1) Synthesis of Intermediate 54-1



    [0247] 5 g of 1-bromo-4-methylbenzene was dissolved in THF and cooled to a temperature of -78°C. 12.3 mL of n-BuLi (2.5M in hexane) was slowly added dropwise thereto while maintaining the temperature. After 1 hour, 5 g of Intermediate 2-3 dissolved in THF was slowly added dropwise to the reaction vessel. When the reaction was complete, the temperature was slowly raised to room temperature, and the reaction was terminated by addition of a saturated ammonium chloride solution. The reaction was extracted three times using ethyl acetate. The organic solution was dried over magnesium sulfate and distilled under reduced pressure. The residue obtained therefrom was separated and purified by silica gel column chromatography to obtain 4.8 g (yield: 66%) of Intermediate 54-1.

    [0248] C31H25BrO M+1: 493.11.

    (2) Synthesis of Intermediate 54-2



    [0249] 3.6 g (yield: 75%) of Intermediate 54-2 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-5, except that 4.8 g of Intermediate 54-1 was used.

    [0250] C31H23Br M+1: 475.10

    (3) Synthesis of Compound 54



    [0251] 3.8 g (yield: 79%) of Compound 54 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of N-phenyldibenzo[b,d]furan-2-amine was used instead of N-phenyl-[1,1'-diphenyl]-4-amine, and 3.5 g of Intermediate 54-2 was used instead of Intermediate 2-5.

    [0252] C49H35NO M+1: 654.27.

    [0253] 1H NMR (500 MHz, CDCl3) δ= 7.84(m, 1H), 7.74-7.65(m, 4H), 7.63(m, 1H), 7.55-7.46(m, 4H), 7.44(m, 1H, 7.32(dt, 1H), 7.13-6.98(m, 7H), 6.95(dd, 1H), 6.86(m, 4H), 6.67(dt, 1H), 6.42(d, 1H), 6.30(m, 3H), 2.34(s, 3H), 2.32(s, 3H).

    Synthesis Example 9: Synthesis of Compound 64



    [0254] 


    (1) Synthesis of Intermediate 64-1



    [0255] 6.6 g (yield: 90%) of Intermediate 64-1 was obtained in substantially the same manner as in the Synthesis of Intermediate 54-1, except that 5.5 g of 1-bromo-4-fluorobenzene was used.

    [0256] C29H19BrF2O M+1: 501.06.

    (2) Synthesis of Intermediate 64-2



    [0257] 5.3 g (83%) of Intermediate 64-2 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-5, except that 6.6 g of Intermediate 64-1 was used instead of Intermediate 2-4.

    [0258] C29H17BrF2 M+1: 484.05.

    (3) Synthesis of Compound 64



    [0259] 3.4 g (yield: 80%) of Compound 64 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 3 g of 9,9-dimethyl-N-phenyl-9H-fluoren-2-amine was used instead of N-phenyl-[1,1'-diphenyl]-4-amine, and 3 g of Intermediate 64-2 was used instead of Intermediate 2-5.

    [0260] C50H35F2N M+1 : 688.27.

    [0261] 1H NMR (500 MHz, CDCl3) δ= 7.78(td, 1H), 7.72-7.64(m, 3H), 7.63(m, 1H), 7.58(d, 1H), 7.50(d, 1H), 7.36-7.27(m, 2H), 7.14-7.00(m, 9H), 6.72(dd, 1H), 6.66(td, 1H), 6.51-6.46(m, 4H), 6.42(dd, 1H), 6.33(dd, 2H), 6.22(m, 2H), 1.62(s, 6H).

    Synthesis Example 10: Synthesis of Compound 81



    [0262] 



    [0263] 3.7 g (yield: 74%) of Compound 81 was obtained in substantially the same manner as in the Synthesis of Compound 21, except that 3 g of Intermediate 81-1 was used instead of Intermediate 16-2.

    [0264] C51H35N M+1: 662.28.

    [0265] 1H NMR (500 MHz, CDCl3) δ= 7.78-7.62(m, 7H), 7.57-7.32(m, 11H), 7.31 (dt, 1H), 7.18-7.01 (m, 8H), 6.96(t, 1H), 6.78-6.75(m, 4H), 6.41 (m, 2H), 5.71 (dd, 1H).

    Synthesis Example 11: Synthesis of Compound 95



    [0266] 



    [0267] 2.5 g (yield: 86%) of Compound 95 was obtained in substantially the same manner as in the Synthesis of Compound 11, except that 2.5 g of Intermediate 95-1 was used instead of Intermediate 2-5.

    [0268] C47H31NO M+1: 626.24.

    [0269] 1H NMR (500 MHz, CDCl3) δ= 7.79-7.66(m, 5H), 7.49-7.44(m, 2H), 7.36-7.27(m, 4H), 7.21-7.19(m, 4H), 7.14-7.01(m, 10H), 6.69-6.60(m, 2H), 6.39(dd, 1H), 6.34(m, 2H), 6.05(d, 1H).

    Synthesis Example 12: Synthesis of Compound 98



    [0270] 



    [0271] 2.9 g (yield: 85%) of Compound 98 was obtained in substantially the same manner as in the Synthesis of Compound 2, except that 2.5 g of Intermediate 98-1 was used instead of 3 g of Intermediate 2-5.

    [0272] C47H33N M+1: 612.26.

    [0273] 1H NMR (500 MHz, CDCl3) δ= 7.92(d, 1H), 7.67-7.58(m, 4H), 7.54-7.30(m, 7H), 7.26-7.01 (m, 13H), 6.94(dd, 1H), 6.83(m, 2H), 6.65(dt, 1H), 6.57(dd, 1H), 6.22(m, 2H), 5.58(t, 1H).

    Synthesis Example 13: Synthesis of Compound 112



    [0274] 


    (1) Synthesis of Intermediate 112-2



    [0275] 8.8 g (yield: 68%) of Compound 112-2 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-3, except that 8.4 g of methyl 2-bromobenzoate (112-1) was used instead of methyl 5-bromo-2-iodobenzoate, and 10 g of (5-bromonaphthalen-1-yl)boronic acid was used instead of naphthalene-1-boronic acid.

    [0276] C18H13BrO2 : M+1 341.01

    (2) Synthesis of Intermediate 112-3



    [0277] 8.5 g (yield: 71%) of Intermediate 112-3 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-4, except that 8.8 g of Intermediate 112-2 was used instead of Intermediate 2-3.

    [0278] C29H21BrO : M+1 465.08.

    (3) Synthesis of Intermediate 112-4



    [0279] 6.6 g (yield: 81%) of Intermediate 112-4 was obtained in substantially the same manner as in the Synthesis of Intermediate 2-5, except that 8.5 g of Intermediate 112-3 was used instead of Intermediate 2-4.

    [0280] C29H19Br: M+1 447.07.

    (4) Synthesis of Compound 112



    [0281] 3.1 g (yield: 71%) of Compound 112 was obtained in substantially the same manner as in the Synthesis of Compound 16, except that 2.8 g of Intermediate 112-4 was used instead of Intermediate 16-2.

    [0282] C50H37N : M+1 652.29.

    [0283] 1H NMR (500 MHz, CDCl3) δ= 7.81(td, 1H), 7.76(td, 1H), 7.63(d, 1H), 7.55(td, 1H), 7.51(dd, 1H), 7.45(dt, 1H),7.36-7.25(m, 2H), 7.22-7.01(m, 15H), 6.86(td, 1H), 6.81(d, 1H), 6.65-6.59(m, 2H), 6.37(dd, 1H), 6.31(m, 1H), 6.12-6.08(m, 2H), 1.61(s, 6H).

    Synthesis Example 14: Synthesis of Compound 124



    [0284] 



    [0285] 2.7 g (yield: 75%) of Compound 124 was obtained in substantially the same manner as in the Synthesis of Compound 16, except that 2.6 g of Intermediate 124-1 was used instead of Intermediate 16-2.

    [0286] C56H41N : M+1 728.32.

    [0287] 1H NMR (500 MHz, CDCl3) δ= 8.15(d, 1H), 8.07-8.03(m, 2H), 7.78(d, 1H), 7.70(d, 1H), 7.60-7.55(m, 2H), 7.51-7.43(m, 2H), 7.41-7.28(m, 4H), 7.25-7.18(m, 4H), 7.13-7.02(m, 10 H), 6.88(d, 1H), 6.72-6.70(m, 2H), 6.42(m, 2H), 6.29(d, 1H), 6.22(m, 2H), 1.62(s, 6H).

    Synthesis Example 15: Synthesis of Compound 136



    [0288] 



    [0289] 2.3 g (yield: 69%) of Compound 136 was obtained in substantially the same manner as in the Synthesis of Compound 16, except that 2.3 g of Intermediate 136-1 was used instead of Intermediate 16-2.

    [0290] C50H36FN : M+1 670.28.

    [0291] 1H NMR (500 MHz, CDCl3) δ= 7.78 (td, 1H), 7.74(dd, 1H), 7.58-7.52(m, 2H), 7.48-7.40(m, 2H), 7.36-7.28(m, 1H), 7.25-7.20(m, 4H), 7.18- 7.05(m, 11H), 6.96(d, 1H), 6.72(dd, 1H), 6.66(t, 1H), 6.42-6.39(m, 2H), 6.29(d, 1H), 6.22(m, 2H), 1.62(s, 6H).

    [Examples]


    Comparative Example 1



    [0292] A Corning 15 Ω/cm2 (1,200 Å) ITO glass substrate was cut to a size of 50 mm x 50 mm x 0.7 mm, sonicated with isopropyl alcohol and pure water each for 5 minutes, and then cleaned by exposure to ultraviolet rays and ozone for 30 minutes. Then, the ITO glass substrate was provided to a vacuum deposition apparatus for use as an anode.

    [0293] 2-TNATA was vacuum-deposited on the ITO glass substrate to form a hole injection layer having a thickness of 600 Å, and 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) (a hole transport material) was vacuum-deposited on the hole injection layer to form a hole transport layer having a thickness of 300 Å.

    [0294] 9,10-di(naphthalen-2-yl)anthracene (DNA) (a blue fluorescent host) and 4,4'-bis[2-(4-(N,N-diphenylamino)phenyl)vinyl]biphenyl (DPAVBi) (a blue fluorescent dopant) was co-deposited on the hole transport layer at a weight ratio of 98:2 to form an emission layer having a thickness of 300 Å.

    [0295] Then, Alq3 was deposited on the emission layer to form an electron transport layer having a thickness of 300 Å. LiF (an alkali metal halide) was deposited on the electron transport layer to form an electron injection layer having a thickness of 10 Å. Al was vacuum-deposited on the electron injection layer to form a cathode electrode having a thickness of 3,000 Å, thereby forming a LiF/AI electrode. In this manner, an organic light-emitting device was manufactured.




    Comparative Example 2



    [0296] An organic light-emitting device was manufactured in substantially the same manner as Comparative Example 1, except that Compound A was used instead of NPB in forming a hole transport layer.




    Comparative Example 3



    [0297] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound B was used instead of NPB in forming a hole transport layer.


    Comparative Example 4



    [0298] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound C was used instead of NPB in forming a hole transport layer.


    Comparative Example 5



    [0299] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound D was used instead of NPB in forming a hole transport layer.


    Comparative Example 6



    [0300] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound E was used instead of NPB in forming a hole transport layer.


    Comparative Example 7



    [0301] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound F was used instead of NPB in forming a hole transport layer.




    Comparative Example 8



    [0302] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound G was used instead of NPB in forming a hole transport layer.


    Example 1



    [0303] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 2 was used instead of NPB in forming a hole transport layer.

    Example 2



    [0304] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 10 was used instead of NPB in forming a hole transport layer.

    Example 3



    [0305] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 11 was used instead of NPB in forming a hole transport layer.

    Example 4



    [0306] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 16 was used instead of NPB in forming a hole transport layer.

    Example 5



    [0307] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 21 was used instead of NPB in forming a hole transport layer.

    Example 6



    [0308] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 34 was used instead of NPB in forming a hole transport layer.

    Example 7



    [0309] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 38 was used instead of NPB in forming a hole transport layer.

    Example 8



    [0310] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 54 was used instead of NPB in forming a hole transport layer.

    Example 9



    [0311] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 64 was used instead of NPB in forming a hole transport layer.

    Example 10



    [0312] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 81 was used instead of NPB in forming a hole transport layer.

    Example 11



    [0313] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 95 was used instead of NPB in forming a hole transport layer.

    Example 12



    [0314] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 98 was used instead of NPB in forming a hole transport layer.

    Example 13



    [0315] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 110 was used instead of NPB in forming a hole transport layer.

    Example 14



    [0316] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 124 was used instead of NPB in forming a hole transport layer.

    Example 15



    [0317] An organic light-emitting device was manufactured in substantially the same manner as in Comparative Example 1, except that Compound 136 was used instead of NPB in forming a hole transport layer.

    [0318] The device performance (driving voltage, luminance, efficiency) at a current density of 50 mA/cm2 and the half lifespan at a current density of 100 mA/cm2 of the organic light-emitting devices manufactured according to Comparative Examples 1 to 8 and Examples 1 to 15 were measured using the following methods, and results thereof are shown in Table 1.
    • Luminance: A current-voltage meter (Keithley SMU 236) supplied power, and luminance was measured by using a luminance meter PR650.
    • Efficiency: A current-voltage meter (Keithley SMU 236) supplied power, and efficiency was measured by using a luminance meter PR650.


    [0319] The half lifespan indicates an amount of time (hr) that lapsed when luminance was 50% of initial luminance (100%) (at 100 mA/cm2).
    Table 1
     Hole transport materialDriving voltage (V)Current density (mA/cm2)Luminan ce (cd/m2)Efficiency (cd/A)Emission colorHalf lifespan (hr @100 mA/cm2)
    Comparative Example 1 NPB 7.01 50 2645 5.29 Blue 258
    Comparative Example 2 Compound A 6.31 50 2775 5.55 Blue 283
    Comparative Example 3 Compound B 6.21 50 2810 5.62 Blue 299
    Comparative Example 4 Compound C 6.11 50 2755 5.51 Blue 305
    Comparative Example 5 Compound D 6.42 50 2775 5.55 Blue 220
    Comparative Example 6 Compound E 6.89 50 2330 4.66 Blue 210
    Comparative Example 7 Compound F 6.60 50 2615 5.23 Blue 243
    Comparative Example 8 Compound G 6.76 50 2310 4.62 Blue 200
    Example 1 Compound 2 4.89 50 3410 6.82 Blue 412
    Example 2 Compound 10 4.87 50 3435 6.87 Blue 406
    Example 3 Compound 11 4.64 50 3385 6.77 Blue 419
    Example 4 Compound 16 4.56 50 3460 6.92 Blue 423
    Example 5 Compound 21 4.67 50 3475 6.95 Blue 410
    Example 6 Compound 34 4.72 50 3440 6.88 Blue 408
    Example 7 Compound 38 4.79 50 3280 6.56 Blue 420
    Example 8 Compound 54 4.81 50 3360 6.72 Blue 392
    Example 9 Compound 64 4.92 50 3440 6.88 Blue 381
    Example 10 Compound 81 4.99 50 3460 6.92 Blue 399
    Example 11 Compound 95 4.87 50 3265 6.53 Blue 378
    Example 12 Compound 98 4.83 50 3265 6.53 Blue 388
    Example 13 Compound 110 4.89 50 3235 6.47 Blue 391
    Example 14 Compound 124 4.82 50 3280 6.56 Blue 368
    Example 15 Compound 136 4.87 50 3115 6.23 Blue 368


    [0320] Referring to Table 1, when the compounds disclosed herein were used as a hole transport material for an organic light-emitting device, the organic light-emitting devices of Examples 1-15 exhibited excellent I-V-L characteristics including a low driving voltage and improved efficiency, as compared with the organic light-emitting device of Comparative Example 1, which used NPB. In particular, the lifespan improvement effect was excellent and the lifespan was remarkably improved in Examples 1-15, which used the compound according to one or more embodiments of the present disclosure as a hole transport material. The driving voltage was improved and the efficiency and half lifespan were also excellent compared with Comparative Examples 2 to 8, which use Compounds A to G.

    [0321] It should be understood that the embodiments described herein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as being available for other similar features or aspects in other embodiments.

    [0322] As used herein, expressions such as "at least one of", "one of", "selected from", "at least one selected from", and "one selected from", when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list. Further, the use of "may" when describing embodiments of the present disclosure refers to "one or more embodiments of the present disclosure".

    [0323] As used herein, the terms "use", "using", and "used" may be considered synonymous with the terms "utilize", "utilizing", and "utilized", respectively. Further, the use of "may" when describing embodiments of the present disclosure refers to "one or more embodiments of the present disclosure".

    [0324] As used herein, the terms "substantially", "about", and similar terms are used as terms of approximation and not as terms of degree, and are intended to account for the inherent deviations in measured or calculated values that would be recognized by those of ordinary skill in the art.

    [0325] Also, any numerical range recited herein is intended to include all subranges of the same numerical precision subsumed within the recited range. For example, a range of "1.0 to 10.0" is intended to include all subranges between (and including) the recited minimum value of 1.0 and the recited maximum value of 10.0, that is, having a minimum value equal to or greater than 1.0 and a maximum value equal to or less than 10.0, such as, for example, 2.4 to 7.6. Any maximum numerical limitation recited herein is intended to include all lower numerical limitations subsumed therein and any minimum numerical limitation recited in this specification is intended to include all higher numerical limitations subsumed therein.

    [0326] While one or more embodiments have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the scope as defined by the following claims.


    Claims

    1. An organic light-emitting device comprising:

    a first electrode;

    a second electrode facing the first electrode; and

    an organic layer between the first electrode and the second electrode,

    wherein the organic layer comprises an emission layer,a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, and

    the hole transport region comprises at least one amine-based compound represented by one of Formulae 1-1 to 1-6:















    wherein:

    i) when the amine-based compound is represented by Formula 1-1, R2 to R10 are each hydrogen;

    ii) when the amine-based compound is represented by Formula 1-2, R8 and R9 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a methyl group, an ethyl group, a propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a ter-butyl group, a pentyl group, an iso-amyl group, a hexyl group, a phenyl group, and a biphenyl group, and R1, R3 to R7, and R10 are each hydrogen;

    iii) when the amine-based compound is represented by Formula 1-3, R1, R2, and R4 to R10 are each hydrogen;

    iv) when the amine-based compound is represented by Formula 1-4, R1 to R3 and R5 to R10 are each hydrogen;

    v) when the amine-based compound is represented by Formula 1-5, R1 to R7 and R9 to R10 are each hydrogen;

    vi) when the amine-based compound is represented by Formula 1-6, R2 is selected from hydrogen, deuterium, -F, -CI, -Br, -I, a methyl group, an ethyl group, a propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a ter-butyl group, a pentyl group, an iso-amyl group, a hexyl group, and a biphenyl group, and R1, R3 to R8, and R10 may each be hydrogen;

    L1, and L2 are each independently a substituted or unsubstituted C5-C60 carbocyclic group or a substituted or unsubstituted C2-C60 heterocyclic group,

    a1 and a2 are each independently an integer from 0 to 5, wherein, when a1 is two or more, two or more L1(s) are identical to or different from each other, and when a2 is two or more, two or more L2(s) are identical to or different from each other,

    when a1 is zero, *-(L1)a1-*' is a single bond, and when a2 is zero, *-(L2)a2-*' is a single bond,

    Ar1 and Ar2 are each independently selected from:

    a benzene group; and

    a benzene group substituted with at least one selected from deuterium, -F, -CI, - Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, a C2-C20 heteroaryl group, and -Si(Q31)(Q32)(Q33),

    R11 and R12 are each independently selected from groups represented by any of Formulae 6-1 to 6-10, 6-12 to 6-18, and 6-27 to 6-34:









    wherein, in Formulae 6-1 to 6-10, 6-12 to 6-18 and 6-27 to 6-34,

    Ph indicates a phenyl group, and

    * indicates a binding site to a neighboring atom,

    b1 and b2 are each independently an integer from 1 to 10, wherein, when b1 is two or more, two or more R11(s) are identical to or different from each other, and when b2 is two or more, two or more R12(s) are identical to or different from each other,

    at least one substituent of the substituted C5-C60 carbocyclic group and the substituted C2-C60 heterocyclic group, is selected from:

    deuterium (-D), -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group;

    a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group, each substituted with at least one selected from deuterium, -F, -CI, - Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q11)(Q12)(Q13), -B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11), and -P(=O)(Q11)(Q12);

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;

    a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, -Si(Q21)(Q22)(Q23), - B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21), and -P(=O)(Q21)(Q22); and

    -Si(Q31)(Q32)(Q33), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31), and -P(=O)(Q31)(Q32),

    Q1 to Q3, Q11 to Q13, Q21 to Q23, and Q31 to Q33 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C1-C60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, and

    * indicates a binding site to a neighboring atom.


     
    2. An organic light-emitting device according to claim 1, wherein L1, and L2 are each independently selected from:

    a benzene group, a pentalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, an acenaphthalene group, a fluorene group, a spiro-fluorene group, a benzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphenylene group, a hexacene group, a pyrrole group, an imidazole group, a pyrazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an iso-indole group, an indole group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a carbazole group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzoxazole group, a benzimidazole group, a furan group, a benzofuran group, a thiophene group, a benzothiophene group, a thiazole group, an isothiazole group, a benzothiazole group, an isoxazole group, an oxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a benzoxazole group, a dibenzofuran group, a dibenzothiophene group, a benzocarbazole group, and a dibenzocarbazole group; and

    a benzene group, a pentalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, an acenaphthalene group, a fluorene group, a spiro-fluorene group, a benzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphenylene group, a hexacene group, a pyrrole group, an imidazole group, a pyrazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an iso-indole group, an indole group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a carbazole group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzoxazole group, a benzimidazole group, a furan group, a benzofuran group, a thiophene group, a benzothiophene group, a thiazole group, an isothiazole group, a benzothiazole group, an isoxazole group, an oxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a benzoxazole group, a dibenzofuran group, a dibenzothiophene group, a benzocarbazole group, and a dibenzocarbazole group, each substituted with at least one selected from deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, a C2-C20 heteroaryl group, and -Si(Q31)(Q32)(Q33).


     
    3. An organic light-emitting device according to claim 1 or claim 2, wherein L1 and L2 are each independently selected from groups represented by any of Formulae 3-1 to 3-46:



















    wherein, in Formulae 3-1 to 3-46,

    Y1 is O, S, C(Z3)(Z4), N(Z5), or Si(Z6)(Z7),

    Z1 to Z7 are each independently selected from hydrogen, deuterium, -F, -CI, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C1-C20 alkyl group, a C1-C20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, and - Si(Q31)(Q32)(Q33),

    d2 is an integer from 0 to 2, wherein, when d2 is two, two Z1(s) are identical to or different from each other,

    d3 is an integer from 0 to 3, wherein, when d3 is two or more, two or more Z1(s) are identical to or different from each other and two or more Z2(s) are identical to or different from each other,

    d4 is an integer from 0 to 4, wherein, when d4 is two or more, two or more Z1(s) are identical to or different from each other,

    d5 is an integer from 0 to 5, wherein, when d5 is two or more, two or more Z1(s) are identical to or different from each other and two or more Z2(s) are identical to or different from each other,

    d6 is an integer from 0 to 6, wherein, when d6 is two or more, two or more Z1(s) are identical to or different from each other and two or more Z2(s) are identical to or different from each other,

    d8 is an integer from 0 to 8, wherein, when d8 is two or more, two or more Z1(s) are identical to or different from each other, and

    * and *' each indicate a binding site to a neighboring atom.


     
    4. An organic light-emitting device according to any one of claims 1 to 3, wherein a1 and a2 are each independently 0 or 1.
     
    5. An organic light-emitting device comprising:

    a first electrode;

    a second electrode facing the first electrode; and

    an organic layer between the first electrode and the second electrode,

    wherein the organic layer comprises an emission layer, a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, and

    the hole transport region comprises at least one amine-based compound selected from any of Compounds 1 to 7, 9 to 19 and 21 to 144:










































































     
    6. An organic light-emitting device according to any one of claims 1 to 5, wherein:

    the first electrode is an anode,

    the second electrode is a cathode,

    the organic layer further comprises an electron transport region between the emission layer and the second electrode,

    the hole transport region comprises a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and

    the electron transport region comprises a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof.


     
    7. An organic light-emitting device according to any one of claims 1 to 6, wherein the hole transport region comprises the hole transport layer, and the hole transport layer comprises the amine-based compound.
     
    8. An organic light-emitting device according to any one of claims 1 to 7, wherein the emission layer comprises the amine-based compound.
     
    9. An organic light-emitting device according to any one of claims 1 to 8, wherein:

    the hole transport region comprises a p-dopant, and

    the p-dopant has a lowest unoccupied molecular orbital (LUMO) level of -3.5 eV or less.


     
    10. An organic light-emitting device according to any one of claims 1 to 9, wherein the emission layer comprises at least one selected from a styryl-based compound, an anthracene-based compound, a pyrene-based compound, and a spiro-bifluorene-based compound.
     
    11. An organic light-emitting device according to any one of claims 1 to 10, wherein:

    the emission layer is a first emission layer for emitting first color light,

    the organic light-emitting device further comprises, between the first electrode and the second electrode, i) at least one second emission layer for emitting second color light or ii) at least one second emission layer for emitting second color light and at least one third emission layer for emitting third color light,

    a maximum emission wavelength of the first color light, a maximum emission wavelength of the second color light, and a maximum emission wavelength of the third color light are identical to or different from one another, and

    the first color light and the second color light are emitted in the form of mixed light, or the first color light, the second color light, and the third color light are emitted in the form of mixed light.


     


    Ansprüche

    1. Organische lichtemittierende Vorrichtung, umfassend:

    eine erste Elektrode;

    eine der ersten Elektrode zugewandte zweite Elektrode; und

    eine organische Schicht zwischen der ersten Elektrode und der zweiten Elektrode,

    wobei die organische Schicht eine Emissionsschicht, eine Löchertransportregion zwischen der ersten Elektrode und der Emissionsschicht und eine Elektronentransportregion zwischen der Emissionsschicht und der zweiten Elektrode umfasst, und

    die Löchertransportregion mindestens eine auf Amin basierende Verbindung umfasst, die durch eine der Formeln 1-1 bis 1-6 dargestellt ist:











    wobei:

    i) wenn die auf Amin basierende Verbindung durch Formel 1-1 dargestellt ist, R2 bis R10 jeweils Wasserstoff sind;

    ii) wenn die auf Amin basierende Verbindung durch Formel 1-2 dargestellt ist, R8 und R9 jeweils unabhängig ausgewählt sind aus Wasserstoff, Deuterium, -F, -Cl, -Br, -I, einer Methylgruppe, einer Ethylgruppe, einer Propylgruppe, einer iso-Propylgruppe, einer n-Butylgruppe, einer iso-Butylgruppe, einer sec-Butylgruppe, einer ter-Butylgruppe, einer Pentylgruppe, einer iso-Amylgruppe, einer Hexylgruppe, einer Phenylgruppe und einer Biphenylgruppe, und R1, R3 bis R7, und R10 jeweils Wasserstoff sind;

    iii) wenn die auf Amin basierende Verbindung durch Formel 1-3 dargestellt ist, R1, R2, und R4 bis R10 jeweils Wasserstoff sind;

    iv) wenn die auf Amin basierende Verbindung durch Formel 1-4 dargestellt ist, R1 bis R3 und R5 bis R10 jeweils Wasserstoff sind;

    v) wenn die auf Amin basierende Verbindung durch Formel 1-5 dargestellt ist, R1 bis R7 und R9 bis R10 jeweils Wasserstoff sind;

    vi) wenn die auf Amin basierende Verbindung durch Formel 1-6 dargestellt ist, R2 ausgewählt ist aus Wasserstoff, Deuterium, -F, -Cl, -Br, -I, einer Methylgruppe, einer Ethylgruppe, einer Propylgruppe, einer iso-Propylgruppe, einer n-Butylgruppe, einer iso-Butylgruppe, einer sec-Butylgruppe, einer ter-Butylgruppe, einer Pentylgruppe, einer iso-Amylgruppe, einer Hexylgruppe und einer Biphenylgruppe, und R1, R3 bis R8, und R10 jeweils Wasserstoff sein können;

    L1 und L2 jeweils unabhängig eine substituierte oder unsubstituierte carbocyclische C5-C60-Gruppe oder eine substituierte oder unsubstituierte heterocyclische C2-C60-Gruppe sind,

    a1 und a2 jeweils unabhängig eine ganze Zahl von 0 bis 5 sind, wobei, wenn a1 zwei oder mehr ist, zwei oder mehr L1(s) identisch mit- oder verschiedenen voneinander sind, und wenn a2 zwei oder mehr ist, zwei oder mehr L2(s) identisch mit- oder verschieden voneinander sind,

    wenn a1 null ist, -(L1)a1-' eine Einfachbindung ist, und wenn a2 null ist, -(L2)a2-' eine Einfachbindung ist,

    Ar1 und Ar2 jeweils unabhängig ausgewählt sind aus:

    einer Benzengruppe; und

    einer Benzengruppe, substituiert mit mindestens einem, ausgewählt aus Deuterium, -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Aminogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C1-C20-Alkylgruppe, einer C1-C20-Alkoxygruppe, einer C6-C20-Arylgruppe, einer C2-C20-Heteroarylgruppe und -Si(Q31)(Q32)(Q33),

    R11 und R12 jeweils unabhängig aus Gruppen ausgewählt sind, die dargestellt sind durch eine der Formeln 6-1 bis 6-10, 6-12 bis 6-18, und 6-27 bis 6-34:









    wobei, in Formeln 6-1 bis 6-10, 6-12 bis 6-18, und 6-27 bis 6-34,

    Ph eine Phenylgruppe angibt, und

    eine Bindungsstelle zu einem Nachbaratom angibt,

    b1 und b2 jeweils unabhängig eine ganze Zahl von 1 bis 10 sind, wobei, wenn b1 zwei oder mehr ist, zwei oder mehr R11(s) identisch mit- oder verschieden voneinander sind, und wenn b2 zwei oder mehr ist, zwei oder mehr R12(s) identisch mit- oder verschieden voneinander sind,

    mindestens ein Substituent der substituierten carbocyclischen C5-C60-Gruppe und der substituierten heterocyclischen C2-C60-Gruppe ausgewählt ist aus:

    Deuterium (-D), -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C1-C60-Alkylgruppe, einer C2-C60-Alkenylgruppe, einer C2-C60-Alkinylgruppe und einer C1-C60-Alkoxygruppe;

    einer C1-C60-Alkylgruppe, einer C2-C60-Alkenylgruppe, einer C2-C60-Alkinylgruppe und einer C1-C60-Alkoxygruppe, jeweils substituiert mit mindestens einem, ausgewählt aus Deuterium, -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C3-C10-Cycloalkylgruppe, einer C1-C10-Heterocycloalkylgruppe, einer C3-C10-Cycloalkenylgruppe, einer C1-C10-Heterocycloalkenylgruppe, einer C6-C60-Arylgruppe, einer C6-C60-Aryloxygruppe, einer C6-C60-Arylthiogruppe, einer C1-C60-Heteroarylgruppe, einer einwertigen nichtaromatischen kondensierten polycyclischen Gruppe, einer einwertigen nichtaromatischen kondensierten heteropolycyclischen Gruppe, -Si(Q11)(Q12)(Q13), -B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11) und -P(=O)(Q11)(Q12);

    einer C3-C10-Cycloalkylgruppe, einer C1-C10-Heterocycloalkylgruppe, einer C3-C10-Cycloalkenylgruppe, einer C1-C10-Heterocycloalkenylgruppe, einer C6-C60-Arylgruppe, einer C6-C60-Aryloxygruppe, einer C6-C60-Arylthiogruppe, einer C1-C60-Heteroarylgruppe, einer einwertigen nichtaromatischen kondensierten polycyclischen Gruppe und einer einwertigen nichtaromatischen kondensierten heteropolycyclischen Gruppe;

    einer C3-C10-Cycloalkylgruppe, einer C1-C10-Heterocycloalkylgruppe, einer C3-C10-Cycloalkenylgruppe, einer C1-C10-Heterocycloalkenylgruppe, einer C6-C60-Arylgruppe, einer C6-C60-Aryloxygruppe, einer C6-C60-Arylthiogruppe, einer C1-C60-Heteroarylgruppe, einer einwertigen nichtaromatischen kondensierten polycyclischen Gruppe und einer einwertigen nichtaromatischen kondensierten heteropolycyclischen Gruppe, jeweils substituiert mit mindestens einem, ausgewählt aus Deuterium, -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C1-C60-Alkylgruppe, einer C2-C60-Alkenylgruppe, einer C2-C60-Alkinylgruppe, einer C1-C60-Alkoxygruppe, einer C3-C10-Cycloalkylgruppe, einer C1-C10-Heterocycloalkylgruppe, einer C3-C10-Cycloalkenylgruppe, einer C1-C10-Heterocycloalkenylgruppe, einer C6-C60-Arylgruppe, einer C6-C60-Aryloxygruppe, einer C6-C60-Arylthiogruppe, einer C1-C60-Heteroarylgruppe, einer einwertigen nichtaromatischen kondensierten polycyclischen Gruppe, einer einwertigen nichtaromatischen kondensierten heteropolycyclischen Gruppe, -Si(Q21)(Q22)(Q23), -B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21) und -P(=O)(Q21)(Q22); und

    -Si(Q31)(Q32)(Q33), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) und -P(=O)(Q31)(Q32),

    Q1 bis Q3, Q11 bis Q13, Q21 bis Q23, und Q31 bis Q33 jeweils unabhängig ausgewählt sind aus Wasserstoff, Deuterium, -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C1-C60-Alkylgruppe, einer C2-C60-Alkenylgruppe, einer C2-C60-Alkinylgruppe, einer C1-C60-Alkoxygruppe einer C3-C10-Cycloalkylgruppe, einer C1-C10-Heterocycloalkylgruppe, einer C3-C10-Cycloalkenylgruppe, einer C1-C10-Heterocycloalkenylgruppe, einer C6-C60-Arylgruppe, einer C1-C60-Heteroarylgruppe, einer einwertigen nichtaromatischen kondensierten polycyclischen Gruppe, einer einwertigen nichtaromatischen kondensierten heteropolycyclischen Gruppe, einer Biphenylgruppe und einer Terphenylgruppe, und

    eine Bindungsstelle zu einem Nachbaratom angibt.


     
    2. Organische lichtemittierende Vorrichtung nach Anspruch 1, wobei L1 und L2 jeweils unabhängig ausgewählt sind aus:

    einer Benzengruppe, einer Pentalengruppe, einer Indengruppe, einer Naphthalingruppe, einer Azulengruppe, einer Heptalengruppe, einer Indacengruppe, einer Acenaphthalingruppe, einer Fluorengruppe, einer Spiro-Fluorengruppe, einer Benzofluorengruppe, einer Phenalengruppe, einer Phenanthrengruppe, einer Anthracengruppe, einer Fluoranthengruppe, einer Triphenylengruppe, einer Pyrengruppe, einer Chrysengruppe, einer Naphthacengruppe, einer Picengruppe, einer Perylengruppe, einer Pentaphenylengruppe, einer Hexacengruppe, einer Pyrrolgruppe, einer Imidazolgruppe, einer Pyrazolgruppe, einer Pyridingruppe, einer Pyrazingruppe, einer Pyrimidingruppe, einer Pyridazingruppe, einer iso-Indolgruppe, einer Indolgruppe, einer Indazolgruppe, einer Puringruppe, einer Chinolingruppe, einer Isochinolingruppe, einer Benzochinolingruppe, einer Phthalazingruppe, einer Naphthyridingruppe, einer Chinoxalingruppe, einer Chinazolingruppe, einer Cinnolingruppe, einer Carbazolgruppe, einer Phenanthridingruppe, einer Acridingruppe, einer Phenanthrolingruppe, einer Phenazingruppe, einer Benzoxazolgruppe, einer Benzimidazolgruppe, einer Furangruppe, einer Benzofurangruppe, einer Thiophengruppe, einer Benzothiophengruppe, einer Thiazolgruppe, einer Isothiazolgruppe, einer Benzothiazolgruppe, einer Isoxazolgruppe, einer Oxazolgruppe, einer Triazolgruppe, einer Tetrazolgruppe, einer Oxadiazolgruppe, einer Triazingruppe, einer Benzoxazolgruppe, einer Dibenzofurangruppe, einer Dibenzothiophengruppe, einer Benzocarbazolgruppe und einer Dibenzocarbazolgruppe; und

    einer Benzengruppe, einer Pentalengruppe, einer Indengruppe, einer Naphthalingruppe, einer Azulengruppe, einer Heptalengruppe, einer Indacengruppe, einer Acenaphthalingruppe, einer Fluorengruppe, einer Spiro-Fluorengruppe, einer Benzofluorengruppe, einer Phenalengruppe, einer Phenanthrengruppe, einer Anthracengruppe, einer Fluoranthengruppe, einer Triphenylengruppe, einer Pyrengruppe, einer Chrysengruppe, einer Naphthacengruppe, einer Picengruppe, einer Perylengruppe, einer Pentaphenylengruppe, einer Hexacengruppe, einer Pyrrolgruppe, einer Imidazolgruppe, einer Pyrazolgruppe, einer Pyridingruppe, einer Pyrazingruppe, einer Pyrimidingruppe, einer Pyridazingruppe, einer iso-Indolgruppe, einer Indolgruppe, einer Indazolgruppe, einer Puringruppe, einer Chinolingruppe, einer Isochinolingruppe, einer Benzochinolingruppe, einer Phthalazingruppe, einer Naphthyridingruppe, einer Chinoxalingruppe, einer Chinazolingruppe, einer Cinnolingruppe, einer Carbazolgruppe, einer Phenanthridingruppe, einer Acridingruppe, einer Phenanthrolingruppe, einer Phenazingruppe, einer Benzoxazolgruppe, einer Benzimidazolgruppe, einer Furangruppe, einer Benzofurangruppe, einer Thiophengruppe, einer Benzothiophengruppe, einer Thiazolgruppe, einer Isothiazolgruppe, einer Benzothiazolgruppe, einer Isoxazolgruppe, einer Oxazolgruppe, einer Triazolgruppe, einer Tetrazolgruppe, einer Oxadiazolgruppe, einer Triazingruppe, einer Benzoxazolgruppe, einer Dibenzofurangruppe, einer Dibenzothiophengruppe, einer Benzocarbazolgruppe und einer Dibenzocarbazolgruppe, jeweils substituiert mit mindestens einem, ausgewählt aus Deuterium, -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Aminogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C1-C20-Alkylgruppe, einer C1-C20-Alkoxygruppe, einer C6-C20-Arylgruppe, einer C2-C20-Heteroarylgruppe und -Si(Q31)(Q32)(Q33).


     
    3. Organische lichtemittierende Vorrichtung nach Anspruch 1 oder Anspruch 2, wobei L1 und L2 jeweils unabhängig aus Gruppen ausgewählt sind, die dargestellt sind durch eine der Formeln 3-1 bis 3-46:



















    wobei, in Formeln 3-1 bis 3-46,

    Y1 O, S, C(Z3)(Z4), N(Z5) oder Si(Z6)(Z7) ist,

    Z1 bis Z7 jeweils unabhängig ausgewählt sind aus Wasserstoff, Deuterium, -F, -Cl, -Br, -I, einer Hydroxylgruppe, einer Cyanogruppe, einer Nitrogruppe, einer Amidinogruppe, einer Hydrazinogruppe, einer Hydrazonogruppe, einer C1-C20-Alkylgruppe, einer C1-C20-Alkoxygruppe, einer Cyclopentylgruppe, einer Cyclohexylgruppe, einer Cycloheptylgruppe, einer Cyclopentenylgruppe, einer Cyclohexenylgruppe, einer Phenylgruppe, einer Biphenylgruppe, einer Naphthylgruppe, einer Fluorenylgruppe, einer Spiro-Bifluorenylgruppe, einer Phenalenylgruppe, einer Phenanthrenylgruppe, einer Anthracenylgruppe, einer Fluoranthenylgruppe, einer Triphenylenylgruppe, einer Pyridinylgruppe, einer Pyrazinylgruppe, einer Pyrimidinylgruppe, einer Chinolinylgruppe, einer Isochinolinylgruppe, einer Benzochinolinylgruppe, einer Naphthyridinylgruppe, einer Chinoxalinylgruppe, einer Chinazolinylgruppe, einer Carbazolylgruppe, einer Phenanthridinylgruppe, einer Acridinylgruppe, einer Phenanthrolinylgruppe, einer Phenazinylgruppe, einer Triazinylgruppe, einer Dibenzofuranylgruppe, einer Dibenzothiophenylgruppe und -Si(Q31)(Q32)(Q33),

    d2 eine ganze Zahl von 0 bis 2 ist, wobei, wenn d2 zwei ist, zwei Z1(s) identisch mit- oder verschieden voneinander sind,

    d3 eine ganze Zahl von 0 bis 3 ist, wobei, wenn d3 zwei oder mehr ist, zwei oder mehr Z1(s) identisch mit- oder verschieden voneinander sind und zwei oder mehr Z2(s) identisch mit- oder verschieden voneinander sind,

    d4 eine ganze Zahl von 0 bis 4 ist, wobei, wenn d4 zwei oder mehr ist, zwei oder mehr Z1(s) identisch mit- oder verschieden voneinander sind,

    d5 eine ganze Zahl von 0 bis 5 ist, wobei, wenn d5 zwei oder mehr ist, zwei oder mehr Z1(s) identisch mit- oder verschieden voneinander sind und zwei oder mehr Z2(s) identisch mit- oder verschieden voneinander sind,

    d6 eine ganze Zahl von 0 bis 6 ist, wobei, wenn d6 zwei oder mehr ist, zwei oder mehr Z1(s) identisch mit- oder verschieden voneinander sind und zwei oder mehr Z2(s) identisch mit- oder verschieden voneinander sind,

    d8 eine ganze Zahl von 0 bis 8 ist, wobei, wenn d8 zwei oder mehr ist, zwei oder mehr Z1(s) identisch mit- oder verschieden voneinander sind, und

    und ∗' jeweils eine Bindungsstelle zu einem Nachbaratom angeben.


     
    4. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 3, wobei a1 und a2 jeweils unabhängig 0 oder 1 sind.
     
    5. Organische lichtemittierende Vorrichtung, umfassend:

    eine erste Elektrode;

    eine der ersten Elektrode zugewandte zweite Elektrode; und

    eine organische Schicht zwischen der ersten Elektrode und der zweiten Elektrode,

    wobei die organische Schicht eine Emissionsschicht, eine Löchertransportregion zwischen der ersten Elektrode und der Emissionsschicht und eine Elektronentransportregion zwischen der Emissionsschicht und der zweiten Elektrode umfasst, und

    die Löchertransportregion mindestens eine auf Amin basierende Verbindung umfasst, die ausgewählt ist aus einer der Verbindungen 1 bis 7, 9 bis 19, und 21 bis 144:










































































     
    6. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 5, wobei:

    die erste Elektrode eine Anode ist,

    die zweite Elektrode eine Kathode ist,

    die organische Schicht ferner eine Elektronentransportregion zwischen der Emissionsschicht und der zweiten Elektrode umfasst,

    die Löchertransportregion eine Löcherinjektionsschicht, eine Löchertransportschicht, eine Emissionshilfsschicht, eine Elektronenblockierschicht, oder eine beliebige Kombination davon, umfasst, und

    die Elektronentransportregion eine Pufferschicht, eine Löcherblockierschicht, eine Elektronensteuerschicht, eine Elektronentransportschicht, eine Elektroneninjektionsschicht, oder eine beliebige Kombination davon, umfasst.


     
    7. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 6, wobei die Löchertransportregion die Löchertransportschicht umfasst, und die Löchertransportschicht die auf Amin basierende Verbindung umfasst.
     
    8. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 7, wobei die Emissionsschicht die auf Amin basierende Verbindung umfasst.
     
    9. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 8, wobei:

    die Löchertransportregion einen p-Dotanden umfasst, und

    der p-Dotand ein Niveau des niedrigsten unbesetzten Molekülorbitals (LUMO) von -3,5 eV oder weniger aufweist.


     
    10. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 9, wobei die Emissionsschicht mindestens eine umfasst, die ausgewählt ist aus einer auf Styryl basierenden Verbindung, einer auf Anthracen basierenden Verbindung, einer auf Pyren basierenden Verbindung und einer auf Spiro-Bifluoren basierenden Verbindung.
     
    11. Organische lichtemittierende Vorrichtung nach einem der Ansprüche 1 bis 10, wobei:

    die Emissionsschicht eine erste Emissionsschicht zum Emittieren von Licht einer ersten Farbe ist,

    die organische lichtemittierende Vorrichtung ferner, zwischen der ersten Elektrode und der zweiten Elektrode, i) mindestens eine zweite Emissionsschicht zum Emittieren von Licht einer zweiten Farbe oder ii) mindestens eine zweite Emissionsschicht zum Emittieren von Licht einer zweiten Farbe und mindestens eine dritte Emissionsschicht zum Emittieren von Licht einer dritten Farbe umfasst,

    eine maximale Emissionswellenlänge des Lichts der ersten Farbe, eine maximale Emissionswellenlänge des Lichts der zweiten Farbe und eine maximale Emissionswellenlänge des Lichts der dritten Farbe identisch mit- oder verschieden voneinander sind, und

    das Licht der ersten Farbe und das Licht der zweiten Farbe in Form von gemischtem Licht emittiert werden, oder das Licht der ersten Farbe, das Licht der zweiten Farbe und das Licht der dritten Farbe in Form von gemischtem Licht emittiert werden.


     


    Revendications

    1. Dispositif organique électroluminescent comprenant :

    une première électrode ;

    une deuxième électrode faisant face à la première électrode ; et

    une couche organique entre la première électrode et la deuxième électrode,

    dans lequel la couche organique comprend une couche d'émission, une région de transport de trous entre la première électrode et la couche d'émission et une région de transport d'électrons entre la couche d'émission et la deuxième électrode, et

    la région de transport de trous comprend au moins un composé à base d'amine représenté par l'une des Formules 1-1 à 1-6 :











    dans lequel :

    i) lorsque le composé à base d'amine est représenté par la Formule 1-1, R2 à R10 sont chacun un hydrogène ;

    ii) lorsque le composé à base d'amine est représenté par la Formule 1-2, R8 et R9 sont sélectionnés chacun indépendamment parmi hydrogène, deutérium, -F, -Cl, -Br, -I, un groupe méthyle, un groupe éthyle, un groupe propyle, un groupe isopropyle, un groupe n-butyle, un groupe isobutyle, un groupe sec-butyle, un groupe ter-butyle, un groupe pentyle, un groupe iso-amyle, un groupe hexyle, un groupe phényle et un groupe biphényle, et R1, R3 à R7 et R10 sont chacun un hydrogène ;

    iii) lorsque le composé à base d'amine est représenté par la Formule 1-3, R1, R2 et R4 à R10 sont chacun un hydrogène ;

    iv) lorsque le composé à base d'amine est représenté par la Formule 1-4, R1 à R3 et R5 à R10 sont chacun un hydrogène ;

    v) lorsque le composé à base d'amine est représenté par la Formule 1-5, R1 à R7 et R9 à R10 sont chacun un hydrogène ;

    vi) lorsque le composé à base d'amine est représenté par la Formule 1-6, R2 est sélectionné parmi hydrogène, deutérium, -F, -Cl, -Br, -I, un groupe méthyle, un groupe éthyle, un groupe propyle, un groupe isopropyle, un groupe n-butyle, un groupe isobutyle, un groupe sec-butyle, un groupe ter-butyle, un groupe pentyle, un groupe iso-amyle, un groupe hexyle et un groupe biphényle, et R1, R3 à R8 et R10 peuvent être chacun un hydrogène ;

    L1 et L2 sont chacun indépendamment un groupe carbocyclique en C5-C60 substitué ou non substitué ou un groupe hétérocyclique en C2-C60 substitué ou non substitué,

    a1 et a2 sont chacun indépendamment un entier de 0 à 5, dans lequel, lorsque a1 est deux ou plus, deux L1(s) ou plus sont identiques ou différents les uns des autres, et lorsque a2 est deux ou plus, deux L2(s) ou plus sont identiques ou différents les uns des autres,

    lorsque a1 est zéro, -(L1)a1-' est une liaison simple, et lorsque a2 est zéro, -(L2)a2-' est une liaison simple,

    Ar1 et Ar2 sont sélectionnés chacun indépendamment parmi :

    un groupe benzène ; et

    un groupe benzène substitué par au moins l'un sélectionné parmi deutérium, -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amino, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe alkyle en C1-C20, un groupe alcoxy en C1-C20, un groupe aryle en C6-C20, un groupe hétéroaryle en C2-C20 et -Si(Q31)(Q32)(Q33),

    R11 et R12 sont sélectionnés chacun indépendamment parmi des groupes représentés par l'une quelconque des Formules 6-1 à 6-10, 6-12 à 6-18 et 6-27 à 6-34 :









    dans lequel, dans les Formules 6-1 à 6-10, 6-12 à 6-18 et 6-27 à 6-34,

    Ph indique un groupe phényle, et

    indique un site de liaison à un atome voisin,

    b1 et b2 sont chacun indépendamment un entier de 1 à 10, dans lequel, lorsque b1 est deux ou plus, deux R11(s) ou plus sont identiques ou différents les uns des autres, et lorsque b2 est deux ou plus, deux R12(s) ou plus sont identiques ou différents les uns des autres,

    au moins un substituant du groupe carbocyclique en C5-C60 substitué et du groupe hétérocyclique en C2-C60 substitué, est sélectionné parmi :

    deutérium (-D), -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe alkyle en C1-C60, un groupe alcényle en C2-C60, un groupe alcynyle en C2-C60 et un groupe alcoxy en C1-C60 ;

    un groupe alkyle en C1-C60, un groupe alcényle en C2-C60, un groupe alcynyle en C2-C60 et un groupe alcoxy en C1-C60, substitués chacun par au moins l'un sélectionné parmi deutérium, -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe cycloalkyle en C3-C10, un groupe hétérocycloalkyle en C1-C10, un groupe cycloalcényle en C3-C10, un groupe hétérocycloalcényle en C1-C10, un groupe aryle en C6-C60, un groupe aryloxy en C6-C60, un groupe arylthio en C6-C60, un groupe hétéroaryle en C1-C60, un groupe polycyclique condensé non aromatique monovalent, un groupe hétéropolycyclique condensé non aromatique monovalent, -Si(Q11)(Q12)(Q13), -B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11) et -P(=O)(Q11)(Q12) ;

    un groupe cycloalkyle en C3-C10, un groupe hétérocycloalkyle en C1-C10, un groupe cycloalcényle en C3-C10, un groupe hétérocycloalcényle en C1-C10, un groupe aryle en C6-C60, un groupe aryloxy en C6-C60, un groupe arylthio en C6-C60, un groupe hétéroaryle en C1-C60, un groupe polycyclique condensé non aromatique monovalent et un groupe hétéropolycyclique condensé non aromatique monovalent ;

    un groupe cycloalkyle en C3-C10, un groupe hétérocycloalkyle en C1-C10, un groupe cycloalcényle en C3-C10, un groupe hétérocycloalcényle en C1-C10, un groupe aryle en C6-C60, un groupe aryloxy en C6-C60, un groupe arylthio en C6-C60, un groupe hétéroaryle en C1-C60, un groupe polycyclique condensé non aromatique monovalent et un groupe hétéropolycyclique condensé non aromatique monovalent, substitués chacun par au moins l'un sélectionné parmi deutérium, -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe alkyle en C1-C60, un groupe alcényle en C2-C60, un groupe alcynyle en C2-C60, un groupe alcoxy en C1-C60, un groupe cycloalkyle en C3-C10, un groupe hétérocycloalkyle en C1-C10, un groupe cycloalcényle en C3-C10, un groupe hétérocycloalcényle en C1-C10, un groupe aryle en C6-C60, un groupe aryloxy en C6-C60, un groupe arylthio en C6-C60, un groupe hétéroaryle en C1-C60, un groupe hétéroaryle en C1-C60, un groupe polycyclique condensé non aromatique monovalent, un groupe hétéropolycyclique condensé non aromatique monovalent, -Si(Q21)(Q22)(Q23), -B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21) et -P(=O)(Q21)(Q22) ; et -Si(Q31)(Q32)(Q33), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) et -P(=O)(Q31)(Q32),

    Q1 à Q3, Q11 à Q13, Q21 à Q23 et Q31 à Q33 sont sélectionnés chacun indépendamment parmi hydrogène, deutérium, -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe alkyle en C1-C60, un groupe alcényle en C2-C60, un groupe alcynyle en C2-C60, un groupe alcoxy en C1-C60, un groupe cycloalkyle en C3-C10, un groupe hétérocycloalkyle en C1-C10, un groupe cycloalcényle en C3-C10, un groupe hétérocycloalcényle en C1-C10, un groupe aryle en C6-C60, un groupe hétéroaryle en C1-C60, un groupe polycyclique condensé non aromatique monovalent, un groupe hétéropolycyclique condensé non aromatique monovalent, un groupe biphényle et un groupe terphényle, et

    indique un site de liaison à un atome voisin.


     
    2. Dispositif organique électroluminescent selon la revendication 1, dans lequel L1 et L2 sont sélectionnés chacun indépendamment parmi :

    un groupe benzène, un groupe pentalène, un groupe indène, un groupe naphtalène, un groupe azulène, un groupe heptalène, un groupe indacène, un groupe acénaphtalène, un groupe fluorène, un groupe spiro-fluorène, un groupe benzofluorène, un groupe phénalène, un groupe phénanthrène, un groupe anthracène, un groupe fluoranthène, un groupe triphénylène, un groupe pyrène, un groupe chrysène, un groupe naphtacène, un groupe picène, un groupe pérylène, un groupe pentaphénylène, un groupe hexacène, un groupe pyrrole, un groupe imidazole, un groupe pyrazole, un groupe pyridine, un groupe pyrazine, un groupe pyrimidine, un groupe pyradizine, un groupe iso-indole, un groupe indole, un groupe indazole, un groupe purine, un groupe quinoline, un groupe isoquinoline, un groupe benzoquinoline, un groupe phtalazine, un groupe naphtyridine, un groupe quinoxaline, un groupe quinazoline, un groupe cinnoline, un groupe carbazole, un groupe phénanthridine, un groupe acridine, un groupe phénanthroline, un groupe phénazine, un groupe benzoxazole, un groupe benzimidazole, un groupe furane, un groupe benzofurane, un groupe thiophène, un groupe benzothiophène, un groupe thiazole, un groupe isothiazole, un groupe benzothiazole, un groupe isoxazole, un groupe oxazole, un groupe triazole, un groupe tétrazole, un groupe oxadiazole, un groupe triazine, un groupe benzoxazole, un groupe dibenzofurane, un groupe dibenzothiophène, un groupe benzocarbazole et un groupe dibenzocarbazole ; et

    un groupe benzène, un groupe pentalène, un groupe indène, un groupe naphtalène, un groupe azulène, un groupe heptalène, un groupe indacène, un groupe acénaphtalène, un groupe fluorène, un groupe spiro-fluorène, un groupe benzofluorène, un groupe phénalène, un groupe phénanthrène, un groupe anthracène, un groupe fluoranthène, un groupe triphénylène, un groupe pyrène, un groupe chrysène, un groupe naphtacène, un groupe picène, un groupe pérylène, un groupe pentaphénylène, un groupe hexacène, un groupe pyrrole, un groupe imidazole, un groupe pyrazole, un groupe pyridine, un groupe pyrazine, un groupe pyrimidine, un groupe pyridazine, un groupe iso-indole, un groupe indole, un groupe indazole, un groupe purine, un groupe quinoline, un groupe isoquinoline, un groupe benzoquinoline, un groupe phtalazine, un groupe naphtyridine, un groupe quinoxaline, un groupe quinazoline, un groupe cinnoline, un groupe carbazole, un groupe phénanthridine, un groupe acridine, un groupe phénanthroline, un groupe phénazine, un groupe benzoxazole, un groupe benzimidazole, un groupe furane, un groupe benzofurane, un groupe thiophène, un groupe benzothiophène, un groupe thiazole, un groupe isothiazole, un groupe benzothiazole, un groupe isoxazole, un groupe oxazole, un groupe triazole, un groupe tétrazole, un groupe oxadiazole, un groupe triazine, un groupe benzoxazole, un groupe dibenzofurane, un groupe dibenzothiophène, un groupe benzocarbazole et un groupe dibenzocarbazole, substitués chacun par au moins l'un sélectionné parmi deutérium, -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amino, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe alkyle C1-C20, un groupe alcoxy C1-C20, un groupe aryle C6-C20, un groupe hétéroaryle C2-C20 et -Si(Q31(Q32)(Q33).


     
    3. Dispositif organique électroluminescent selon la revendication 1 ou la revendication 2, dans lequel L1 et L2 sont sélectionnés chacun indépendamment parmi des groupes représentés par l'une quelconque des Formules 3-1 à 3-46 :

















    dans lequel, dans les Formules 3-1 à 3-46,

    Y1 est O, S, C(Z3)(Z4), N(Z5) ou Si(Z6)(Z7),

    Z1 à Z7 sont sélectionnés chacun indépendamment parmi hydrogène, deutérium, -F, -Cl, -Br, -I, un groupe hydroxyle, un groupe cyano, un groupe nitro, un groupe amidino, un groupe hydrazino, un groupe hydrazono, un groupe alkyle en C1-C20, un groupe alcoxy en C1-C20, un groupe cyclopentyle, un groupe cyclohexyle, un groupe cycloheptyle, un groupe cyclopentényle, un groupe cyclohexényle, un groupe phényle, un groupe biphényle, un groupe naphtyle, un groupe fluorényle, un groupe spiro-bifluorényle, un groupe phénalényle, un groupe phénanthrényle, un groupe anthracényle, un groupe fluoranthényle, un groupe triphénylényle, un groupe pyridinyle, un groupe pyrazinyle, un groupe pyrimidinyle, un groupe quinolinyle, un groupe isoquinolinyle, un groupe benzoquinolinyle, un groupe naphtyridinyle, un groupe quinoxalinyle, un groupe quinazolinyle, un groupe carbazolyle, un groupe phénanthridinyle, un groupe acridinyle, un groupe phénanthrolinyle, un groupe phénazinyle, un groupe triazinyle, un groupe dibenzofuranyle, un groupe dibenzothiophényle et -Si(Q31)(Q32)(Q33),

    d2 est un entier de 0 à 2, dans lequel, lorsque d2 est deux, deux Z1(s) sont identiques ou différents l'un de l'autre,

    d3 est un entier de 0 à 3, dans lequel, lorsque d3 est deux ou plus, deux Z1(s) ou plus sont identiques ou différents les uns des autres et deux Z2(s) ou plus sont identiques ou différents les uns des autres,

    d4 est un entier de 0 à 4, dans lequel, lorsque d4 est deux ou plus, deux Z1(s) ou plus sont identiques ou différents les uns des autres,

    d5 est un entier de 0 à 5, dans lequel, lorsque d5 est deux ou plus, deux Z1(s) ou plus sont identiques ou différents les uns des autres et deux Z2(s) ou plus sont identiques ou différents les uns des autres,

    d6 est un entier de 0 à 6, dans lequel, lorsque d6 est deux ou plus, deux Z1(s) ou plus sont identiques ou différents les uns des autres et deux Z2(s) ou plus sont identiques ou différents les uns des autres,

    d8 est un entier de 0 à 8, dans lequel, lorsque d8 est deux ou plus, deux Z1(s) ou plus sont identiques ou différents les uns des autres, et

    et ∗' indiquent chacun un site de liaison à un atome voisin.


     
    4. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 3, dans lequel a1 et a2 sont chacun indépendamment 0 ou 1.
     
    5. Dispositif organique électroluminescent comprenant :

    une première électrode ;

    une deuxième électrode faisant face à la première électrode ; et

    une couche organique entre la première électrode et la deuxième électrode,

    dans lequel la couche organique comprend une couche d'émission, une région de transport de trous entre la première électrode et la couche d'émission et une région de transport d'électrons entre la couche d'émission et la deuxième électrode, et

    la région de transport de trous comprend au moins un composé à base d'aminé sélectionné parmi l'un quelconque des Composés 1 à 7, 9 à 19 et 21 à 144 :








































































     
    6. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 5, dans lequel :

    la première électrode est une anode,

    la deuxième électrode est une cathode,

    la couche organique comprend en outre une région de transport d'électrons entre la couche d'émission et la deuxième électrode,

    la région de transport de trous comprend une couche d'injection de trous, une couche de transport de trous, une couche d'émission auxiliaire, une couche de blocage d'électrons ou une combinaison quelconque de celles-ci, et

    la région de transport d'électrons comprend une couche tampon, une couche de blocage de trous, une couche de contrôle d'électrons, une couche de transport d'électrons, une couche d'injection d'électrons ou une combinaison quelconque de celles-ci.


     
    7. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 6, dans lequel la région de transport de trous comprend la couche de transport de trous et la couche de transport de trous comprend le composé à base d'amine.
     
    8. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 7, dans lequel la couche d'émission comprend le composé à base d'amine.
     
    9. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 8, dans lequel :

    la région de transport de trous comprend un dopage de type p, et

    le dopage de type p a un niveau d'orbitale moléculaire inoccupée la plus basse (LUMO) de -3,5 eV ou moins.


     
    10. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 9, dans lequel la couche d'émission comprend au moins l'un sélectionné parmi un composé à base de styryle, un composé à base d'anthracène, un composé à base de pyrène et un composé à base de spiro-bifluorène.
     
    11. Dispositif organique électroluminescent selon l'une quelconque des revendications 1 à 10, dans lequel :

    la couche d'émission est une première couche d'émission pour émettre une lumière d'une première couleur,

    le dispositif organique électroluminescent comprend en outre, entre la première électrode et la deuxième électrode, i) au moins une deuxième couche d'émission pour émettre une lumière d'une deuxième couleur ou ii) au moins une deuxième couche d'émission pour émettre une lumière d'une deuxième couleur et au moins une troisième couche d'émission pour émettre une lumière d'une troisième couleur,

    une longueur d'onde d'émission maximale de lumière de la première couleur, une longueur d'onde d'émission maximale de lumière de la deuxième couleur et une longueur d'onde d'émission maximale de lumière de la troisième couleur sont identiques ou différentes l'une de l'autre, et

    la lumière de la première couleur et la lumière de la deuxième couleur sont émises sous forme de lumière mélangée, ou la lumière de la première couleur, la lumière de la deuxième couleur et la lumière de la troisième couleur sont émises sous forme de lumière mélangée.


     




    Drawing

















    Cited references

    REFERENCES CITED IN THE DESCRIPTION



    This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

    Patent documents cited in the description